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Summary 
The process of Natural Killer (NK) cell adhesion to target cells resulting in NK cell activation and 
cytotoxicity has been the subject of intense research. However, only very little is known about the 
detachment of NK cells from target cells after the lytic hit. Since NK cells are able to kill multiple 
targets in a serial manner, this detachment process could play a pivotal role for an effective cytotoxic 
NK cell response. We therefore established different assay systems, based on flow cytometry and 
microscopy, to study NK cell detachment in more detail. Using these assay systems we could 
demonstrate that recently detached NK cells showed signs of productive conjugates. We found 
evidence for degranulation and observed down-modulation of activating receptors. This was possibly 
caused by internalization after receptor engagement, a mechanism suggested to tune down the 
strength of the interaction between cells. In contrast, plasma membrane-bound metalloproteinases 
that mediate shedding of surface molecules and thereby also possibly decrease contact between effector 
and target cell, were not required. 
In our flow cytometry-based system cultured human NK cells detached from K562 cells with a half-
life of about 50 minutes. A similar trend was observed for the half-lives of NK:HeLa cell-contacts 
analyzed using life cell-microscopy. The maintenance of the NK:K562 conjugates required sustained 
early activating signaling, e.g. via Src- and Syk-family kinases, and was ATP-dependent. In contrast, 
MAP kinase and also PKC! activity did not affect the formation nor the decay of conjugates. To 
investigate the involvement of inhibitory pathways in the detachment process we interfered with 
phosphatases and found that the serine-threonine phosphatase PP1 was important for the stability of 
conjugates. In addition to ongoing signaling, the flexibility of the actin cytoskeleton was indispensable 
to maintain NK:target cell contacts, whereas dynamics of microtubules had only limited impact.  
Investigating the influence of target cell availability on the detachment revealed that contact to a new 
target accelerated the separation from a previous one. Therefore, the contact to a target may keep the 
NK cell in an activated status and thereby may support serial killing. To investigate the role of target 
cell viability on detachment we interfered with the target cell survival on various levels. Inhibition of 
myosin IIA, which is involved in exocytosis of lytic granules, led to reduced lysis and moderately 
decelerated detachment. Depletion of mature perforin by inhibition of the vacuolar H+-ATPase led to 
a complete loss of NK cell cytotoxicity, while the formation of NK:target cell conjugates remained 
unaffected. Interestingly, this resulted in a drastic deceleration of NK cell detachment. If the loss of 
perforin was caused by monensin, a proton ionophor, lysis of target cells was abolished but the half-life 
of NK:target cell conjugates remained unaffected. Taken together these data indicate that not target 
cell survival as such, but some NK cell intrinsic mechanisms affect the detachment process. 
+100"23!
 
 4 
In summary, we established assay systems that allow investigation of the detachment process from 
target cells and we found first evidences that maintenance of conjugates and the detachment are 
regulated processes. Thus, understanding the mechanisms leading to detachment may facilitate efforts 
to increase the efficiency of NK cell-mediated cytotoxicity. 
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Zusammenfassung 
Adhäsion von NK-Zellen an Zielzellen führt zu deren Aktivierung und löst die von ihnen vermittelte 
Zytotoxizität aus. Dieser Prozess ist bereits intensiv erforscht. Über das Ablösen der NK- von 
Zielzellen nach dem Ausführen der Effektorfunktion ist im Gegensatz dazu bisher nur wenig bekannt. 
Da NK-Zellen in der Lage sind mehrere Zielzellen nacheinander zu zerstören, könnte das Ablösen 
eine entscheidende Rolle für eine effektive NK-Zell-vermittelte Immunantwort spielen. Daher haben 
wir verschiedene auf Durchflusszytometrie- und Mikroskopie-basierte Versuchssysteme etabliert, um 
das Freisetzen der Zielzelle von der NK-Zelle genauer zu untersuchen. Mit diesen Versuchssystemen 
konnten wir zeigen, dass kürzlich abgelöste NK-Zellen, Anzeichen produktiver Konjugate zeigten. 
Wir konnten Degranulation nachweisen und beobachteten die Herunterregulierung aktivierender 
Rezeptoren. Eine mögliche Ursache hierfür könnte Rezeptorinternalisierung sein, welche durch die 
Bindung des entsprechenden Liganden ausgelöst werden kann. Es wird angenommen, dass dieser 
Mechanismus die Stärke der Interaktion zwischen Zellen verringert. An die Plasmamembran 
gebundene Matrixmetalloproteinasen können Oberflächenmoleküle abschneiden und dadurch 
ebenfalls zum Verringern des Kontaktes zwischen Effektor- und Zielzelle beitragen. Jedoch zeigte 
deren Inhibierung keinen Einfluss auf die Beständigkeit von NK:Zielzell-Kontakten. 
In unserem Durchflusszytometrie-basierten System bestimmten wir für Konjugate zwischen 
kultivierten humanen NK-Zellen und K652-Zellen eine Halbwertszeit von ungefähr 50 min. Die 
Untersuchung von NK:HeLa-Zellkontakten mittels Lebendzellmikroskopie zeigte eine vergleichbare 
Tendenz für die Halbwertszeit. Neben der Verfügbarkeit von ATP, benötigte die Aufrechterhaltung 
von NK:K562-Konjugaten anhaltende aktivierende Signale, beispielsweise über Src- und Syk-
Kinasen. Dahingegen hatten MAP-Kinasen und PKC! weder auf die Bildung noch auf den Zerfall 
der Konjugate einen Einfluss. Neben kontinuierlichen Signalen, ist die Flexibilität des Aktin-
Zytoskeletts für die Aufrechterhaltung von NK:Zielzell-Kontakten unverzichtbar, wohingegen die 
Dynamik der Mikrotubulie nur von geringer Bedeutung war. 
Weiterhin wurde untersucht, welchen Einfluss die Verfügbarkeit von weiteren Zielzellen auf das 
Ablösen hat. Das Ausbilden des Kontaktes zu einer neuen Zielzelle beschleunigte das Ablösen von der 
ursprünglichen Zielzelle. Das deutet darauf hin, dass der Kontakt zu einer Zielzelle möglicherweise 
den aktivierten Zustand der NK-Zelle aufrecht erhält und dadurch gegebenenfalls serielles Zerstören 
von Zielzellen unterstützt. Um die Rolle der Viabilität der Zielzellen für das Ablösen der NK-Zellen 
zu erforschen, haben wir versucht das Überleben der Zielzelle auf verschiedenen Ebenen zu 
beeinflussen. Inhibierung von Myosin IIA, das bei der Exozytose lytischer Granula benötigt wird, 
führte zu einer reduzierten Zielzelllyse und einem mäßig verlangsamten Zerfall der Konjugate. Durch 
Blockierung der vakuolären H+-ATPase induzierten wir die Depletion von reifem Perforin. Das 
41+"00%*("++1*/!
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verursachte einen kompletten Verlust der NK-Zell-Zytotoxizität wohingegen die Bildung von 
Konjugaten unbeeinflusst blieb. Interessanterweise führte dies zu einer drastischen Verlangsamung des 
Ablösens der NK- von den Zielzellen. Wurde der Verlust von Perforin durch das Protoneninonophor 
Monensin ausgelöst, wurde zwar die Zielzelllyse verhindert, aber die Halbwertszeit der NK:K562-
Konjugate blieb unverändert. Diese Ergebnisse deuten darauf hin, dass nicht das Zielzellüberleben als 
solches, sondern NK-Zell-intrinsische Mechanismen das Freisetzen der Zielzelle beeinflussen. 
In dieser Arbeit stellen wir Versuchssysteme vor, die eine Untersuchung des Ablösungsprozesses der 
NK-Zellen von Zielzellen ermöglichen. Weiterhin haben wir erste Hinweise darauf gefunden, dass 
sowohl die Aufrechterhaltung, als auch das Auflösen von Konjugaten regulierte Prozesse sind. Für 
Bestrebungen die Effizienz der NK-Zell-vermittelten Zytotoxizität zu erhöhen, ist das Verständnis 
der zugrunde liegenden Mechanismen von großer Bedeutung. 
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1. Introduction 
1.1 General Natural Killer cell biology 
Natural killer (NK) cells are essential innate effectors in early immune responses against viral 
infections and transformed cells. They constitute 5-15 % of the lymphocytes in the peripheral blood, 
but are also found in spleen, liver, lung, bone marrow and lymph nodes (Westermann&Pabst, 1992). 
There is a multiplicity of immunodeficiencies accompanied with total absence or impaired NK cell 
function (Orange, 2002). These are mostly caused by single gene mutations and in general associated 
with an increased susceptibility to herpes virus-infections. Additionally, low NK cell activity was 
shown to correlate with increased cancer risk (Imai et al., 2000). Human NK cells are typically 
described as CD56+ CD3- NKp46+ and divided in two distinct subpopulation based on the density of 
CD56 surface expression. CD56bright NK cells, mainly responding to soluble factors, show high 
cytokine and chemokine production. They express comparably low levels of CD16 and are a preceding 
developmental stage to CD56dim NK cells. The latter represent about 90 % of circulating NK cells with 
increased responsiveness to cell surface ligands and thus higher cytotoxic potential (Caligiuri, 2008; 
Long et al., 2013). As B and T cells, NK cells belong to the lymphocyte compartment (Blom&Spits, 
2006), however due to the lack of somatical gene-rearrangement they do not carry clonotypic antigen-
specific receptors (Long et al., 2013). Instead they express germ line-encoded receptors that bind to 
conserved molecular structures.  
Induction of NK cell effector functions is tightly regulated by integration of activating and inhibitory 
signals (Long et al., 2013). During encounter of susceptible targets signaling cascades are induced that 
lead to activation and the formation of the activating NK cell immunological synapse (aNKIS), 
culminating in cytotoxic effector functions. Three main mechanisms for target cell elimination have 
been described: (i) Directed release of cytolytic effector proteins such as perforin and granzymes 
induces apoptosis of the target cell (Krzewski&Coligan, 2012). (ii) Opsonization of targets with 
immunoglobulins (Igs) induces antibody-mediated cellular cytotoxicity (ADCC) by binding of the Fc 
domain of the Ig to the activating receptor CD16 (Fc"RIIIa) (Lanier et al., 1988). (iii) Binding and 
trimerization of the death receptors tumor necrosis factor-related apoptosis-inducing ligand 
(TRAIL)-R1-5 or Fas on the target cell by the respective ligands TRAIL and FasL on NK cells 
induces receptor-mediated apoptosis (Zamai et al., 1998; Chávez-Galán et al., 2009). Additionally, 
gene-transcription is initiated resulting in release of cytokines, e.g. interferon (IFN)-", tumor necrosis 
factor (TNF)-# and granulocyte-macrophage colony-stimulating factor (GM-CSF), which are 
important for recruitment and stimulation of other immune cell types (Campbell&Hasegawa, 2013). 
Besides this, regulatory NK cell functions were described. Via release of soluble factors or direct cell-
5*!2'.1)!5'*!
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cell interaction they control other immune cell types, e.g. T cells and dendritic cells (DC) (Tian et al., 
2012; Crome et al., 2013). Through to these activities NK cells have been postulated to play a crucial 
role in prevention of autoimmunity. 
 
Two major mechanisms described for NK cell activation are “missing self” and “induced self” 
recognition.  Kärre and colleagues proposed the “missing self” concept in 1990, stating that NK cells 
recognize and destroy malignant cells that lost self-MHC-I (Ljunggren&Karre, 1990; Karre, 2002). 
In healthy individuals NK cells bind MHC class I molecules expressed on autologous cells via 
inhibitory receptors e.g. Killer cell immunoglobulin-like receptors (KIRs). In contrast, during cellular 
stress expression of ligands for activating receptors is induced, triggering NK cell-mediated 
cytotoxicity. This “induced self” hypothesis was initially described for the activating receptor NKG2D 
(Diefenbach&Raulet, 2001) and later proposed to be also true for NKp30 (Kellner et al., 2012).  
The strength of NK cell responsiveness is determined during their development. Interestingly, NK 
cells that lack inhibitory receptors for self-MHC I and thereby can not receive inhibitory signals 
become hyporesponsive, a mechanism required for self-tolerance (Raulet et al., 2001; Fernandez et al., 
2005; Raulet, 2006). Recently, several models for this education process have been postulated. The 
“disarming model” suggests, that if NK cells constantly receive activating impulses with lacking 
inhibition they turn hyporesponsive. The “arming model” in contrast, proposes that NK cells become 
responsive through signals of at least one ITIM-bearing receptor that recognizes self-MHC-I 
(Raulet&Vance, 2006). This should prevent autoreactivity caused by lacking inhibition by self-MHC-
I. This last model is also described with the word “licensing” (Kim et al., 2005). Recently, it was 
shown that licensing is reversible, depending on the MHC I-environment (Joncker et al., 2010). 
Another model, introduced by Brodin and colleagues in 2009 is the “rheostat model” stating that the 
more inhibitory signals could be received the higher is the responsiveness of the NK cell (Brodin et al., 
2009; Joncker et al., 2009). The common feature of all these models is that NK cells express at least 
one functional inhibitory receptor specific for self-MHC-I to acquire functional competence. 
 
Another emerging and surprising discovery in NK cell biology is the hypothesis of an NK cell 
memory, which initially was believed to be an exclusive feature of the adaptive immune system. Recent 
studies show that under certain circumstances NK cells mediate long-lived memory responses (Min-
Oo et al., 2013). In mouse-systems three different origins of the memory-phenotype have been 
described: (i) mouse cytomegalovirus (MCMV)-induced memory, (ii) cytokine-induced memory and 
(iii) liver-restricted memory that is associated with recognition of haptens and thereby seem to be 
antigen-specific. Nevertheless, the relevance for the human system still has to be evaluated. But there 
are indications that certain virus infections, e.g. with cytomegalovirus (CMV), induce long-lived 
5*!2'.1)!5'*!
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specific NK cells (Min-Oo et al., 2013). The mechanisms and conditions of this feature are still not 
understood and subject of intense research. Deciphering this new concept would lead to another 
fundamental change in understanding the significance of NK cells for immunity. 
 
1.2 The complexity of NK cell-mediated directed cellular cytotoxicity 
The encounter of an NK cell with a susceptible target cell cumulating in directed cellular cytotoxicity 
is highly regulated and complex and requires the formation of the aNKIS. Initially, the immunological 
synapse (IS) was described for T cell interaction with antigen presenting cells (APCs) as “combination 
of a specialized junction, cell polarization, and positional stability” (Paul&Seder, 1994; Dustin et al., 
1998). In 1999, Davis and colleagues showed that also NK cells formed synapses during inhibitory 
NK-target cell interactions (Davis et al., 1999). Two years later, activating Natural Killer cell synapses 
were described for the first time (Vyas et al., 2001). Until today immunological synapses as feature of 
cell-cell-interaction have also been found between other cell types of the immune system as well as 
between immune and non-immune cells (Orange, 2008). Understanding the IS as spatially and 
temporally structured rearrangement of various molecules, several functions for the IS in signaling, 
secretion and protein transfer have been postulated (Roda-Navarro&Reyburn, 2007; 
Krzewski&Strominger, 2008; Orange, 2008). The accumulation of adhesion molecules enables a firm 
attachment of the NK cell to the target cell, which supports ligation of a multitude of NK cell 
receptors. The formation of a thin cavity between NK and target cell, the so-called “synaptic cleft” 
facilitates directed release of lytic granules without harming bystander cells. Additionally, the small 
size of the cavity might ensure a high local concentration of the released effector molecules. This 
might also be important in terms of multiple killing events, since the reduced amount of cytolytic 
molecules required for one target saves energy. Recruitment of receptors and associating signaling 
molecules leads to local signal amplification. This accumulation might be one mechanism to facilitate 
overcoming of concentration-dependent activation thresholds. Furthermore, some studies describe the 
exchange of membrane fragments and embedded proteins between the two interacting cells (Onfelt et 
al., 2004; Roda-Navarro et al., 2004; Roda-Navarro&Reyburn, 2007). The purpose of this mechanism 
is still debated, but it might have a role in recycling mechanisms and regulation of NK cell activity. 
Moreover, it was also described to be involved in spreading of pathogens (Roda-Navarro&Reyburn, 
2007; Krzewski&Strominger, 2008). 
 
1.2.1 The Natural Killer cell immunological synapse 
The process of synapse formation was reviewed in detail by J. S. Orange in 2008 and recently by Mace 
and colleagues (Orange, 2008; Mace et al., 2014). Although the steps occur in a certain sequence, a 
5*!2'.1)!5'*!
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linear descriptions of the events is difficult since most events occur simultaneously. Additionally, 
redundancy of signaling molecules and synergy of signaling pathways induced by coactivating 
receptors were described, indicating the complexity of this process. (Orange et al., 2003; Wulfing et 
al., 2003; Orange, 2008).  The different stages of the aNKIS are pictured in figure 1.1 and can be 
roughly divided in (i) loose adhesion and ligation of integrins and receptors leading to initial signaling; 
(ii) actin cytoskeleton rearrangements and strengthening adhesion; (iii) recruitment and clustering of 
receptors promoting increased and sustained signaling; (iv) microtubule cytoskeleton reorganization; 
(v) granule convergence to the microtubule organizing center (MTOC) and polarization of MTOC/lytic 
granules to the IS; (vii) degranulation and recycling and (viii) disassembly of the IS. 
 
 
Fig. 1.1: Stages of the formation of the activating Natural Killer cell synapse. (Orange, 2008) 
 
 
Dying target cell
Nature Reviews | Immunology
a   Initiation stage
b   Effector stage
c   Termination stage
1: Cell–cell approximation
2: Cell–cell association
 3: Adhesion
 4: Activation signalling
 5: Firm adhesion
 6: Activation signalling
 17: Lytic-granule docking
 18: Lytic-granule priming (?)
 19: Lytic-granule fusion
 20: Lytic-granule release
 21: Relative inactivity
 22: Receptor downregulation
 23: Detachment
 24: Recycling of cytolytic potential
 7: Actin reorganization
 8: Receptor clustering
 9: Raft membrane clustering
 10: Activation signalling
 11: Minus-ended lytic-granule
  movement
 12: MTOC polarization
 13: MTOC anchoring
 14: Actin clearance
 15: Plus-ended lytic-granule
  movement (?)
 16: Lytic-granule transit
  through cortex
MTOC
NK cell
Lytic granule
Lipid raft
Activating
receptor
Activating
receptor ligand
Adhesion
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receptor ligand
F-actin
cortex
Target
cell
Accumulated
F-actin
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Figure 2 | Model for sequential stages in the formation and function of the NK-cell lytic synapse. It is proposed 
that the formation of  functional natural killer (NK)-cell lytic sy pse can be divid d into three main stag s — initiati n 
(a), effector (b) and termination (c) — that are each subdivided into multiple steps. Important steps that are proposed  
to occur in the initiation stage include adhesion and initial signalling for cell activation. In the effector stage, key steps 
include actin reorganization, receptor clustering, polarization of the microtubule-organizing centre (MTOC) and lytic 
granules, and lytic-granule fusion with the plasma membrane. The crucial steps of the termination stage are proposed to 
include a period of inactivity and detachment. The specific time required to progress through the various stages varies and 
is likely to be a feature of the given target cell and the activation state of the NK cell. A linear progression between certain 
steps (such as the requirement of actin reorganization for MTOC polarization) has been proven experimentally, whereas 
the linearity between other steps remains hypothetical at present. The inhibitory synapse (see BOX 3) has been shown  
to halt the progression of lytic-synapse formation by interfering with the late steps of the initiation stage (activation 
signalling) and early steps in the effector stage (actin reorganization and receptor clustering). F-actin, filamentous actin.
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The initiation of the aNKIS formation 
In the first tethering-like contact between NK and target cells adhesion molecules as integrins and 
selectins are bound initiating adhesion and signaling. Binding of the integrin lymphocyte function-
associated antigen (LFA)-1 to intercellular adhesion molecules (ICAM)-1, -2 or -3 on the target cell is 
crucial for directed NK cell cytotoxicity (Bryceson et al., 2005). Subsequently, intracellular association 
of talin to LFA-1 is required for recruitment of vinculin, G-actin, and the actin polymerization 
machinery, including the actin nucleating protein complex Arp2/3 and Wiskott-Aldrich Syndrome-
protein (WASp) (Mace et al., 2009; Mace et al., 2010; Ham et al., 2013). 
Additionally, upon ICAM-1 binding, Src-mediated phosphorylation of Vav1 inducing the Vav1-Rac1 
pathway is required to initiate actin cytoskeleton rearrangements (Riteau et al., 2003). Besides talin, 
availability of paxillin as well as activity of spleen tyrosine kinase (Syk), phospholipase C (PLC)-y and 
protein kinase C (PKC) were found to be essential for LFA-1-induced granule-polarization 
(March&Long, 2011). T cells require inside-out signals via activating receptors to induce 
conformational changes in LFA-1, that induce increased affinity and full function of the molecule. 
There are data suggesting that, although binding of activating receptors as 2B4 increases adhesion, 
LFA-1 can up-regulate its own adhesion by self-mediated inside-out signaling (Barber&Long, 2003; 
Hoffmann et al., 2011). However, co-stimulation of activating receptors is essential for the formation 
of a mature immunological synapse (Culley et al., 2009).  
 
Subsequent to LFA-1 ligation, recruitment of activating receptors to the contact zone is induced 
enabling augmentation of activating interaction with the target cell. As shown in figure 1.2, NK cells 
express a vast variety of activating receptors which either signal on their own or associate with adaptor 
molecules as Fc$R1"-, TCR%-chains, DAP10 or DAP12 (Watzl&Long, 2010; Watzl&Urlaub, 2012; 
Koch et al., 2013; Long et al., 2013). The basis for activating signaling are either immunoreceptor 
tyrosine-based activation motifs (ITAMs) or other tyrosine-based activation motifs in the cytoplasmic 
tail of the receptor or the adaptor molecule. An overview of the induction of the main activating 
signaling pathways is shown in figure 1.3. In most cases triggering of a single receptor is not sufficient 
to induce activation. Instead co-stimulation of multiple receptors, occasionally in synergistic pairs, is 
required. The only known exception is Fc receptor Fc"RIIIa (CD16), which can induce undirected 
degranulation after ligation in isolation (Bryceson et al., 2006). 
The activating receptors NKp30, NKp44, NKp46 belong to the family of natural cytotoxicity 
receptors (NCRs). Although it is known that they play an important role in tumor surveillance, only a 
few ligands, mainly viral proteins, are discovered yet (Koch et al., 2013). NKp30 associates with 
CD3%- and possibly Fc$R1"-chains and recognizes the tumor-associated antigens B7-H6 and BAT3 
(Pende et al., 1999; Pogge von Strandmann et al., 2007; Brandt et al., 2009). In contrast to the 
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constitutively expressed NKp30 and NK46, NKp44 expression is induced during activation. It 
associates with DAP12 (Vitale et al., 1998). The proliferating cell nuclear antigen (PCNA) has been 
described as inhibitory cellular ligand for NKp44 (Rosental et al., 2011). In addition, NKp44L has 
recently been described as activating ligand that is expressed on a variety of tumor cell lines (Baychelier 
et al., 2013). NKp46 associates with the CD3%- and Fc$R1"-chain (Vitale et al., 1998). No cellular 
ligand for NKp46 has been discovered yet. After ligation of the receptors the cytoplasmic ITAMs are 
phosphorylated by Src family kinases. This induces recruitment of spleen tyrosine kinase (Syk) and 
zeta chain-associated protein kinase (ZAP)-70 which in turn phosphorylate non-T cell activation 
linker (NTAL) and linker for the activation of T cells (LAT). Subsequently, these transmembrane 
adaptor molecules associate and activate signaling molecules as phosphatidylinositol 3-kinase (PI3K), 
phospholipase C (PLC) "-1/-2 and members of the Vav family, which leads to induction Ca2+ flux, 
cytoskeleton rearrangements, cytotoxicity and cytokine release (Koch et al., 2013). 
 
 
On the contrary, NKG2D, NKp80 and SLAM family receptors signal via non-ITAM-based 
pathways (Watzl&Long, 2010; Long et al., 2013). C-type lectin like molecules, e.g. NKG2D and 
NKp80 are encoded in the Natural Killer gene complex (NKC) (Yokoyama&Plougastel, 2003). 
NKG2D binds to stress-induced ligands of MICA, MICB and ULBPs (López-Larrea et al., 2008). 
The receptor associates with DAP10, which contains a tyrosine-based signaling motif. Phosphorylated 
DAP10 binds PI3K or Grb2. Grb2 further interacts with Vav1. PI3K associated with DAP10 is 
 
Fig. 1.2: Diversity of activating NK cell receptors. (Watzl&Urlaub, 2012) 
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inducing signaling via other guanine nucleotide exchange factors (GEFs) and small GTPases, leading 
to adhesion, granule polarization and degranulation (Watzl&Long, 2010; Long et al., 2013). In 
contrast NKp80, which recognizes the activation-induced C-type lectin (AICL), signals independent 
of adaptor molecules since it contains an atypical hemi-ITAM in its cytoplasmic tail. However, the 
induced signaling pathway is not unraveled yet (Welte et al., 2006; Ruckrich&Steinle, 2013). A third 
group of well characterized activating receptors belong to the family of signaling lymphocytic 
activation molecule (SLAM) related receptors (SRR) (Veillette, 2006). NK cells express NTB-A, 
CRACC and 2B4 (Claus et al., 2008). All except for 2B4, which associates with CD48, display the 
characteristic homophilic binding. Their cytoplasmic part contains immunoreceptor tyrosine-based 
switch motifs (ITSMs). The ITSM in SLAM family receptors is associating with SLAM-associated 
protein (SAP) or Ewing’s sarcoma-associated transcript (EAT)-2. SAP not only recruits Fyn, which 
phosphorylates Vav1 but also blocks binding of the inhibitory phosphatases SHIP-1, SHP-1 and 
SHP-2 (Watzl&Long, 2010). Signaling downstream of EAT-2 has not been resolved yet, although it 
is suggested to be activating. Another molecule of the SLAM receptor-family is CD2, which binds 
CD58 and in humans also weakly to CD48 (Selvaraj et al., 1987; Arulanandam et al., 1993). CD2 is 
recruited quickly the contact site after LFA-1 ligation (Orange et al., 2003) and was reported to be 
required for conjugate formation between NK92 and K562 cells (Zheng et al., 2009). Additionally, as 
also described for NKG2D, DNAM-1 and 2B4 it provides inside-out signals that increase LFA-1 
affinity (Barber&Long, 2003; Bryceson et al., 2009). DNAM-1 does not belong to any of these 
families. It binds CD155 and nectin-2 and plays a role in LFA-1 mediated cellular adhesion (de 
Andrade et al., 2013). DNAM-1 does not associate with an ITAM-bearing adaptor molecule, but gets 
phosphorylated by PKC after receptor cross-linking. The phosphorylation is required for its 
association with LFA-1. Additionally, it was described that if CD2 is costimulated with 2B4 PLC"-2 
is activated (de Andrade et al., 2013).  
 
 
Fig. 1.3: Activating signaling pathways in human NK cells. (Watzl&Urlaub, 2012) 
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Signaling pathways induced by different activating receptors can be synergistic or redundant. But some 
molecules are indispensible for instance, Vav family members or PLC" are required downstream of 
most activating receptors (Watzl&Long, 2010; Koch et al., 2013; Long et al., 2013). 
 
As for T cells, organization of molecules at the NK cell synapse in supramolecular activation clusters 
(SMACs) was described (Orange, 2008; Dustin&Depoil, 2011). In T cells the clusters are further 
subdivided in the TCR-rich central (c) SMAC, the LFA-1-rich peripheral (p) SMAC and the distal 
(d) SMAC rich in F-actin (Dustin&Depoil, 2011). Granule secretion occurs through the pSMAC, to 
not disturb the activating receptor interactions in the cSMAC (Stinchcombe et al., 2001). In NK cells 
activating receptors, LFA-1 and F-actin accumulate in the pSMAC, whereas perforin was located in 
the cSMAC (Orange et al., 2003). However, the importance of the SMAC for cell function is still 
debated since it was found, that signaling events leading to activation also occur outside of the SMAC 
zones (Orange, 2008; Dustin, 2009). 
 
The iNKIS – Prevention of cytotoxicity at early stages 
Some data suggest that, in contrast to other lymphocytes, if the activating signaling in NK cells 
overcomes the inhibitory an “all-or-nothing response” is induced, that might not be tuned further 
(Lagrue et al., 2013). Therefore, inhibition of NK cells is an important mechanism to prevent false 
directed NK cell cytotoxicity. Protection of healthy cells is mediated via inhibition of NK cells by 
receptors of the Killer cell immunoglobulin-like receptor (KIR)-family, the immunoglobulin-like 
transcript (ILT) receptor family or the heterodimer NKG2A/CD94. All of these receptors contain 
immunoreceptor tyrosine-based inhibition motifs (ITMIs) in their cytoplasmic tail. Ligation by their 
cognate ligands induces phosphorylation of the ITIM leading to recruitment of the phosphatases 
SHP-1, -2 or SHIP-1 (Watzl&Long, 2010). SHP-1 inactivates Vav1 by dephosphorylation and 
thereby interrupts activating signaling at a very early and central point (Stebbins et al., 2003). In 
parallel to Vav1 inactivation, phosphorylation of Crk induces its dissociation from a signaling 
complex, which abrogates activating signaling (Peterson&Long, 2008). SHIP-1 reduces the 
phosphatidylinositol 3,4,5-trisphosphate (PIP3) level and thereby interferes with phosphatidyl-
inositol-3-kinase (PI3K) induced signaling (Gumbleton&Kerr, 2013). There are evidences that 
inhibition can occur even earlier via restricting the increase of LFA-1 affinity or the recruitment of 
activating receptors to the contact site (Bryceson et al., 2006; Peterson&Long, 2008; Long et al., 
2013). Additionally, clustering of inhibitory receptors at the contact zone was shown to prevent 
clustering of activating receptors and led to collapse of the actin cytoskeleton inducing retraction of the 
NK cell (Abeyweera et al., 2011).  
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Interestingly, the induced inhibition is locally restricted and does not induce general inhibition of the 
whole cell (Peterson&Long, 2008). Thereby non-susceptible bystander cells are protected if they are 
close enough to a susceptible target to allow simultaneous contact. 
 
The effector stage of the aNKIS formation 
If the activating signals are stronger than the inhibitory the formation of the aNKIS proceeds to the 
effector stage initiated by amplified activating signaling and induction of firm adhesion. The effector 
stage is characterized by actin reorganization, polarization of the degranulation machinery and release 
of cytotoxic granules towards the target cell.  
Downstream of Vav1 activation, formation of F-actin is induced (Orange, 2008; Mace et al., 2009; 
Mace et al., 2010; Ham et al., 2013). A multiplicity of GEFs and GTPases, e.g. Cdc42, Rac1 and the 
recently discovered DOCK8 as well as a number of kinases, e.g. PIPKI" and PKC! are involved in 
this process (Krzewski et al., 2006; Sinai et al., 2010; Carlin et al., 2011; Mace et al., 2012; Ham et al., 
2013). However, details of the signaling pathways are not completely resolved yet. The induced actin 
rearrangements facilitate receptor clustering, lipid-raft clustering and polarization of the whole cell 
and the lytic granules towards the target cell (Fassett et al., 2001; Orange, 2008; Lagrue et al., 2013). 
The accumulation of actin at the cell-cell-contact zone occurs within a few minutes and can persist for 
up to 30 min (Butler&Cooper, 2009).  
 
In addition to actin rearrangements microtubule dynamics are vital for NK cell cytotoxicity since they 
facilitate lytic granule convergence to the microtubule-organizing center (MTOC) and the 
polarization to the contact zone (Katz et al., 1982; Lagrue et al., 2013). However, conjugation with 
the target cell was shown to occur independently of microtubules (Katz et al., 1982). The minus-end 
directed movement of the lytic granules to the MTOC does not require rearrangement of actin or 
microtubules, but is dependent on the motor-protein dynein and existing microtubules (Fig. 1.4 [1]) 
(Mentlik et al., 2010). It rapidly occurs after target cell contact, before the MTOC polarizes towards 
the IS and is a requirement for synapse maturation (Mentlik et al., 2010). Granule convergence 
induced by activating ligands or IL-2 requires Src kinases but no down-stream signaling (James et al., 
2013) and is a prerequisite for polarization to the synapse (Katz et al., 1982; Stinchcombe et al., 2006; 
Banerjee et al., 2007; Mentlik et al., 2010). In contrast, in NK cells triggering of LFA-1 alone is 
sufficient to induce polarization of lytic granules (Barber et al., 2004; Bryceson et al., 2005; Hogg et 
al., 2011). Subsequent of granule convergence to the MTOC, both move towards the synapse. This 
process in contrast to granule convergence is depending on cytoskeletal rearrangements (Mace et al., 
2014) and requires signaling events downstream of Src kinases (Bryceson et al., 2006). Activation of 
PI3K induces the MEK-ERK signaling pathway, but how ERK is involved in microtubule 
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reorganization is not clear (Jiang et al., 2000; Graham et al., 2006; Galandrini et al., 2013). 
Downstream of PI3K PLC" hydrolyses phosphatidylinositol (4,5)-bisphosphate (PIP2) to membrane 
bound diacylglycerol (DAG) and inositol 1,4,5-triphosphate (IP3), which binds to receptors in the 
endoplasmatic reticulum (ER)-membrane inducing Ca2+ release, which is required for signaling and 
MTOC polarization (Bryceson et al., 2006; March&Long, 2011). Additionally, store-operated Ca2+ 
entry (SOCE) depending on ORAI1 and STIM1 is required for degranulation and cytotoxicity, but 
not for inside-out signals of LFA-1 or granule polarization (Maul-Pavicic et al., 2011). A variety of 
other molecules is involved in the movement of the MTOC/lytic granules to cell-cell contract site, e.g. 
Pyk2 (Gismondi et al., 1997; Sancho et al., 2000) or CIP4 (Banerjee et al., 2007). The transit of the 
lytic granules through the F-actin supposedly is mediated by the ATP-dependent motor protein 
myosin IIA (Andzelm et al., 2007; Sanborn et al., 2011). Recently it was shown, that lytic granules 
traverse through hypodense regions in the actin mesh at the synapse (Fig. 1.4 [2]) (Rak et al., 2011; 
Brown et al., 2011) and are highly motile at the IS (Mace et al., 2012).  
 
 
Fig. 1.4: Granule exocytosis in human NK cells and induction of apoptosis in the target cell.  
(Krzewski&Coligan, 2012) 
 
Krzewski and Coligan Lytic granules of NK cells
FIGURE 2 | A model of lytic granule exocytosis from human NK cell. In
response to the engagement of NK cell activating receptors and initiation of
signaling cascades (not depicted), the lytic granules move along the
microtubules toward the MTOC in the dynein-dynactin complex-dependent
manner (1). The MTOC and the granules then polarize toward the NK-target
cell contact area, where granules switch from microtubules to the filamentous
actin network at the immunological synapse (2) and navigate through the
cortical filamentous actin meshwork as a result of the actin motor protein
myosin IIA activity (3). This allows the lytic granules to get into close proximity
of the plasma membrane (PM), and dock at the membrane due to activity of
Rab27a and Rab27a-mediated recruitment of Munc13-4, as well as through the
recognition of syntaxin 11 (STX11) and Munc18-2, possibly by the R-SNARE
protein(s) present at the lytic granule membrane. The docked granules are
then primed (4) by Munc13-4 in response to calcium flux (not shown), likely by
the Munc13-4-mediated switch of STX11 to an open conformation (by removal
of Munc18-2), and/or by Munc13-4 forming an initial bridge between the
granule membrane and the plasma membrane. Finally, the granule-associated
R-SNARE protein(s) (e.g., VAMP7) form a complex with Q-SNARE proteins
present on the plasma membrane (e.g., STX11 and SNAP23) (5), which allows
for the fusion of vesicles with the plasma membrane and release of the
granule content into the synaptic cleft at the immunological synapse. There
are two paradigms describing the entry of perforin and granzymes into target
cells. The internalization model (A) assumes that perforin and granzymes bind
to the target cell plasma membrane and are endocytosed into the early
endosome-like enlargosome. Following internalization, perforin would
mediate formation of pores in the enlargosome membrane (EM), allowing
granzymes to leak into the cytosol of the target cell. According to the plasma
membrane (PM) pore formation model (B), perforin oligomerizes in the plasma
membrane, disrupting its integrity thereby permitting granzymes to enter
from the synaptic cleft into the target cell. After gaining access into the cell
cytosol (C), granzymes start processing their targets, leading to apoptosis
through activation of caspases, induction of mitochondrial damage, and DNA
fragmentation. In addition, FasL and TRAIL from the lytic granules bind to their
receptors on the target cell surface (D) and initiate apoptosis.
more events are required before the granules fuse with the plasma
membrane and their content is released into the synaptic cleft.
Although it has been shown that in human cytotoxic T cells
and NK cells, the polarized MTOC docks at the plasma mem-
brane and that phenomenon was postulated to be sufficient to
facilitate a direct transfer of the lytic granules to the secretory area
of the immunological synapse (Stinchcombe et al., 2006, 2011),
lytic granules in NK cells have to navigate through the cortical
actin network before they can fuse with the plasma membrane
(Brown et al., 2011; Rak et al., 2011; Mace and Orange, 2012).
www.frontiersin.org November 2012 | Volume 3 | Article 335 | 5
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Some activating receptors (e.g. NKp46 or CD2) need co-ligation of LFA-1 to induce this remodeling 
of cortical actin whereas others (e.g. CD16 or NKG2D) do not (Brown et al., 2012). 
 
The docking of the granules at the plasma membrane involve SNARE proteins as Munc13-4, 
Syntaxin 11, Munc18-2 or VAMPs as well as the GTPase Rab27a (Fig. 1.4 [3&4]) (Casey et al., 
2007; Cote et al., 2009; Wood et al., 2009; Liu et al., 2010; Elstak et al., 2011; Krzewski et al., 2011; 
Dabrazhynetskaya et al., 2012; Lopez et al., 2013). Additionally, Munc13-4 and Rab27a have been 
described to facilitate the final maturation of lytic granules before degranulation (Ménager et al., 
2007). Two distinct modes of granule fusion with the plasma membrane have been described 
(Fig. 1.4 [5]). Complete fusion leads to release of the entire content whereas during incomplete fusion 
the content is only partly released (Liu et al., 2011). Following degranulation recycling of vesicles and 
cytotoxic molecules via endocytosis was described as energy saving mechanism in NK cell cytotoxicity 
(Liu et al., 2009; Li et al., 2011; Capuano et al., 2012). The endosomes were shown to polarize 
towards to MTOC (Stinchcombe et al., 2011). Additionally, re-internalization of Munc13-4 was 
observed and proposed to be required for serial killing (Capuano et al., 2012). Recently, two 
independent studies showed that an NK cell could deliver multiple lytic hits towards the same target 
cell (Lopez et al., 2013; Vanherberghen et al., 2013). This might be facilitated by lytic granules that 
arrive consecutively at the synapse (Vanherberghen et al., 2013). 
 
The termination stage of the aNKIS formation 
The termination stage of the aNKIS is characterized by the induction of apoptosis in the target cells 
and the detachment of the NK cell from the target cell. 
Lytic granules are a complex structure containing a variety of molecules as enzymes and lytic proteins. 
Granzymes, perforin and granulysin are the most studied effector molecules. The granules show a 
particular way of packaging these molecules to minimize their activity (Metkar et al., 2002). The 
characteristic acidic intra-luminal pH of lytic granules is established by the membrane-bound vacuolar 
H+-ATPase (Mellman et al., 1986). On one hand, the low pH enables activity of proteolytic enzymes 
required for perforin maturation (Voskoboinik et al., 2010). On the other hand, the low pH renders 
perforin unable to interact with calcium ions required for its activity (Voskoboinik et al., 2005). 
Additionally it was shown that under this condition perforin forms complexes with the proteoglycan 
serglycin, which allows packaging that renders the molecules inactive. However, the requirement of 
serglycin for self-protection is debated (Voskoboinik et al., 2010). Perforin is generated as a 70 kDa 
immature precursor in the ER. Maturation by the cleavage of a C-terminal signaling sequence by 
cathepsin L occurs in the lytic granules (Uellner et al., 1997; Konjar et al., 2010). Granzyme A and B 
are the most abundant members of the granzyme family found in human NK cells (Lieberman, 2003). 
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They are transported to the lytic granules as pro-enzymes and are processed by cathepsin C and H to 
the active form, which also form a complex with serglycin for tight packaging (Krzewski&Coligan, 
2012). During degranulation the cytotoxic molecules are released into the synaptic cleft. The neutral 
pH leads to release of perforin from serglycin and its activation. Subsequently, perforin binds to the 
target cell membrane in a Ca2+-dependent manner and forms pores by oligomerization (Fig. 1.3 [B]) 
(Baran et al., 2009). Interestingly, the NK cell is not affected by the released perforin (Lopez et al., 
2013). Cleavage of perforin by surface cathepsin B or coverage of the NK cell membrane by CD107a 
after degranulation are discussed as possible mechanisms that protect the NK cells (Balaji et al., 2002; 
Cohnen et al., 2013). The perforin pore-formation is a prerequisite for granzyme entry into the target 
cell (Keefe et al., 2005; Thiery et al., 2011). There are different mechanisms debated for granzyme 
uptake. Originally it was postulated that the perforin-pores allow diffusion of granzyme from the 
synaptic cleft into the target cell cytoplasm. More recently, data suggest that granzyme is released into 
the target cell cytoplasm from endosomes in a perforin-dependent way. Endocytosis was described to 
be initiated either as membrane repair response or by binding of the perforin-serglycin-granzyme 
macromolecular complex to Mannose 6-phosphate receptors or to be clathrin-mediated (Fig. 1.4 [A]) 
(Krzewski&Coligan, 2012). Once in the cytoplasm, the highly specific serine proteases induce 
caspase-dependent and –independent apoptosis (Fig. 1.4 [C]). Granzyme B cleaves caspase 3 and 
other caspases leading to induction of the caspase cascade. By cleavage of BH3-interactin domain 
death agonist (BID), granzyme B induces damage of the mitochondrial outer membrane, leading to 
release of pro-apoptotic molecules into the cytoplasm (Wowk&Trapani, 2004). Additionally, it also 
targets the mitochondrial membrane directly without the necessity of cytosolic mediators (Lieberman, 
2003). 
 
There are studies describing the formation of nanotubes between the target and the detaching NK cell 
(Onfelt et al., 2004; Roda-Navarro et al., 2004; Chauveau et al., 2010; Comerci et al., 2012). Several 
functional properties have been proposed for these long thin “closed-ended connections” between NK 
and target cells (Davis, 2009). Chauveau and colleagues found a correlation between nanotube 
formation and target cell lysis (Chauveau et al., 2010). Additionally, accumulation of receptors and 
signaling molecules in nanotubes and the transmission of intercellular calcium fluxes were described 
(Davis, 2009). Furthermore, a recent study found that certain receptor-ligand pairs could promote 
nanotube formation (Comerci et al., 2012). Recent advances in microscopy leading to increased 
resolution might facilitate new insights in the importance of nanotubes for NK cell function.  
 
5*!2'.1)!5'*!
 
 19 
1.3 NK cells are serial killers 
A strategy of NK cells and also cytotoxic T lymphocytes (CTLs) to augment their cytotoxic potential 
is the ability to lyse multiple targets, a mechanism named “serial killing”. It was described first for T 
cells in 1975 by Zagury and colleagues (Zagury et al., 1975) and later in 1981 for NK cells as well 
(Ullberg&Jondal, 1981). Originally the potential to lyse multiple targets was observed in cytotoxicity 
assays, where only the amount of specific lysis compared to the E:T ratio allowed conclusions about 
the average number of targets that could be killed by one effector (Zagury et al., 1975; 
Ullberg&Jondal, 1981). In later studies, time-lapse microscopy allowed live cell imaging and thereby 
the pursuit of individual cells over an extended period of time (Sanderson, 1976; Rothstein et al., 
1978; Bhat&Watzl, 2007; Choi&Mitchison, 2013; Vanherberghen et al., 2013). Recent data suggests, 
that individual NK cells can kill up to 14 targets consecutively (Bhat&Watzl, 2007; Choi&Mitchison, 
2013; Vanherberghen et al., 2013). But this differs strongly between individual cells, since most NK 
cells kill less or not at all (Choi&Mitchison, 2013; Vanherberghen et al., 2013). Supporting these 
observations, Tomescu and colleagues showed that a recently degranulated NK cell is as effective in 
killing as one that did not degranulate before (Tomescu et al., 2009). Recycling mechanisms described 
above for lytic proteins, membrane parts and molecules involved in degranulation, as well as studies 
that indicate rapid de novo formation of lytic granules after target cell recognition would support this 
finding (Liu et al., 2005; Liu et al., 2009; Li et al., 2011; Liu et al., 2011; Capuano et al., 2012). 
However, earlier studies describe exhaustion and induction of apoptosis induced by target cells 
(Bajpai&Brahmi, 1994; Yamauchi et al., 1996; Taga et al., 1999; Poggi et al., 2005; Warren, 2011). 
Choi and Mitchison recently discovered that in sequential killing events, the first kill was slower than 
the following ones. This would suggest that in addition to an increased number of killed targets the 
speed of action is augmented by serial killing. They hypothesized that this is due to integration of the 
signals from the previous and the current target. Therefore, maintaining the contact with the previous 
target until the encounter of a new target keeps the NK cell in an activated status, a mechanism they 
termed “kinetic priming”. This could be facilitated by simultaneous contact with multiple targets, 
which was described (Bhat&Watzl, 2007; Choi&Mitchison, 2013; Lopez et al., 2013). Although 
quick consecutive killing events were observed, so far no evidence indicates, that NK cells could kill 
multiple targets simultaneously, which was described for T cells (Wiedemann et al., 2006; Lopez et 
al., 2013). Understanding and inducing the ability for serial killing could expand the perspective of 
NK and T cell in therapeutic applications, e.g. in cancer treatment. First evidences indicate that 
bispecific antibodies can reinforce serial killing (Hoffmann et al., 2005; Bhat&Watzl, 2007). 
 
To facilitate serial killing as such, the NK cell needs to disengage from the previous target to 
functionally interact with a new one. The synapse breakage and detachment of the NK from the target 
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cell has not yet been studied in detail. Recently, there were a few indications as to when the 
detachment occurs in relation to the target cell death. Vanherberghen and colleagues (2013) analyzed 
NK cell target cell interaction at the single cell level. They observed that fast target cell death induced 
by a strong cytotoxic response led to shorter contacts compared to conjugates with slow target cell 
death. Therefore, they propose that the duration of the contact depends on viability and membrane 
integrity of the target cell. Additionally, they observed that the NK cells remained attached after 
breakage of the synapse and hypothesize that these two mechanisms are independently regulated. 
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2. Aim of the thesis 
For efficient augmentation of NK cell-mediated cytotoxicity by serial killing, the detachment process 
plays a pivotal role. However, only little is known about what exactly induces detachment of NK cells 
from target cells or which events are involved. Since research on events following the lytic hit was just 
emerging, no verified assay systems were available. Therefore, the first objective of the study was to 
establish assay systems that allow investigation of the decay of NK:target cell-conjugates. With these 
tools, we aimed to better characterize the phenotype of detached NK cells and to illuminate events 
that are possibly involved in the detachment process. For that purpose we used inhibitors targeting 
various steps that are known to be indispensible for NK cell cytotoxicity.  
By investigating these diverse aspects possibly involved in detachment, the aim of this study was to 
gain a better understanding of this last step in cytolytic NK:target cell interactions. 
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3. Materials and Methods 
3.1 Materials 
3.1.1 Antibodies 
Goat monoclonal antibodies 
Name (clone) Conjugate Source, Reference 
anti-PKCθ (C19) -- Santa Cruz Biotechnology, Heidelberg, Deutschland 
 
Mouse monoclonal antibodies 
Name (clone) Conjugate Source, Reference 
IgG control (MOPC-21) PE, FITC Biolegend, San Diego, CA, US 
IgG control (MOPC-21) -- Sigma-Aldrich, St. Louis, MO, US 
IgG control (MOPC-31C) Pe/Cy5 BD Biosciences, San Jose, CA, US 
anti-2B4 (C1.7) -- (Valiante&Trinchieri, 1993) 
anti-2B4 (C1.7) FITC, PE Biolegend, San Diego, CA, US 
anti-CD3 (HIT3a) PE Biolegend, San Diego, CA, US 
anti-CD11a (HI111) PE/Cy5 Biolegend, San Diego, CA, US 
anti-CD16 (3G8) PE Biolegend, San Diego, CA, US 
anti-CD56 (MEM-188) FITC, PE Biolegend, San Diego, CA, US 
anti-CD69 (FN50) PE Biolegend, San Diego, CA, US 
anti-CD158a (EB6) PE Beckman Coulter, Krefeld, Germany 
anti-CD158b1/b2 (GL183) PE Beckman Coulter, Krefeld, Germany 
anti-DNAM1 (DX11) PE BD Biosciences, San Jose, CA, US 
anti-LAMP1 (H4A3) FITC, APC Biolegend, San Diego, CA, US 
anti-LAMP1 (H4A3) PE/Cy5 BD Biosciences, San Jose, CA, US 
anti-NKG2A (Z199) PE Beckman Coulter, Krefeld, Germany 
anti-NKG2C (134591) PE R&D, Minneapolis, MN, USA 
anti-NKG2D (149810) -- R&D Systems, Minneapolis, MN USA 
anti-NKG2D (1D11) PE Biolegend, San Diego, CA, US 
anti-NKp30 (p30-15) PE Biolegend, San Diego, CA, US 
anti-NKp44 (P44-8) PE Biolegend, San Diego, CA, US 
anti-NKp46 (9E2) PE Biolegend, San Diego, CA, US 
anti-human perforin (dG9) FITC Biolegend, San Diego, CA, US 
anti-human perforin (Pf-344) -- Mabtech, Hamburg, Germany 
anti-phospho-tyrosine (4G10) biotin Millipore, Temecula, CA, US 
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Rabbit polyclonal antibodies 
Name  Conjugate Source, Reference 
anti-actin -- Sigma-Aldrich, St. Louis, MO, US 
anti-PKCα -- Cell Signaling Technology, Danvers, MA, US 
 
Secondary antibodies 
Name  Conjugate Source, Reference 
donkey-anti-goat IgG (H+L) HRPO Jackson ImmunoResearch Laboratories/ 
Dianova, Hamburg, Germany 
goat-anti-mouse IgG (H+L) HRPO Jackson ImmunoResearch Laboratories/ 
Dianova, Hamburg, Germany 
goat-anti-rabbit IgG (H+L) HRPO Jackson ImmunoResearch Laboratories/ 
Dianova, Hamburg, Germany 
 
3.1.2 Buffers 
2.5 x NRSB (non-reducing sample buffer): 5 % (w/v)  
25 % (v/v)  
0.05 % (w/v)  
0.156 mM 
SDS  
Glycerol  
Bromphenol Blue  
Tris-HCl, pH = 6.8 
 
5 x RSB (reducing sample buffer): 10 % (w/v)  
50 % (v/v)  
25 % (v/v)  
0.1 % (w/v)  
0.3125 mM 
SDS  
Glycerol  
2-Mercaptoethanol  
Bromphenol Blue  
Tris-HCl, pH = 6.8 
 
4 % paraformaldehyde 32 g 
80 mL 
ad 800 mL 
Paraformaldehyde, powder 
10 x PBS 
ddH2O 
Water was heated to 60 °C using a hot plate with stirring. After 
adding PFA powder, the solution was covered and maintained at 
60 °C. NaOH was added and the stirring continued until the 
solution became clear. 10 x PBS was added and the pH adjusted 
to 7.2 using HCl. After filtration the PFA was kept on ice to 
cool down, aliquoted and stored at -20 °C 
   
Annexin V-binding buffer (10 x) 0.1 M 
25 mM 
1.4 M 
Hepes 
CaCl2 
NaCl 
 
FACS-buffer 1 x 
2 % (v/v) 
DPBS (Life Technologies) 
fetal calf serum 
 
PBS (10x) 1.37 M 
27 mM 
100 mM 
18 mM 
NaCl 
KCl 
NaH2PO4 x 2H2O 
KH2PO4 
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PBST/NaCl: 1 x 
0.05 % (v/v) 
0.5 M 
PBS 
Tween 20 
NaCl 
 
MOPS buffer 20x (Invitrogen) 
 
 
 
 
 
 
 
Triton X-100 lysis buffer: 150 mM  
20 mM  
10 % (v/v)  
0.5 % (v/v)  
2 mM 
10 mM  
1 mM  
1 mM 
NaCl  
Tris-HCl, pH 7.4  
Glycerol  
Triton X-100  
EDTA  
NaF  
PMSF  
Na-orthovanadate  
 
   
Western blot transfer buffer: 24 mM  
129 mM  
20 % (v/v) 
Tris  
Glycin  
MeOH 
 
 
3.1.3 Eukaryotic cells 
Culture media, fetal calf serum (FCS), non-essential amino acids and sodium pyruvate were purchased 
from Gibco (Invitrogen/LifeTechnologies, Darmstadt, Germany); human serum from PromoCell 
(Heidelberg, Germany) and purified human interleukin (IL)-2 from the NIH Cytokine Repository 
(Bethesda, MD, US). If not indicated otherwise, all media were supplemented  with 10 % (v/v)  FCS  
and 1 %  (v/v)  penicillin/streptomycin  (Gibco/Invitrogen/LifeTechnologies, Darmstadt, Germany). 
Vericyte medium was obtained from Medicyte (Heidelberg, Germany). 
 
Name Cell type Culture medium 
721.221 Human EBV-transfected B cell line IMDM 
HeLa Human cervical cancer cell line DMEM 
HeLa-CD48 Human cervical cancer cell line, stably 
transfected with human CD48 
DMEM + 1 µg/mL puromycin 
JY Human EBV-transfected B cell line RPMI 1640, 10 % FCS, 1 % P/S, 0,1 % 2-
mercaptoethanol 
K562 Human erythroleukemic cell line IMDM 
Primary human  
  NK cells 
Isolated from peripheral blood 
mononuclear cells (PBMCs) by negative 
selection 
IMDM, 10 % (v/v) human serum, 1 % 
(v/v) non‐essential amino acids, 
1 % (v/v) sodium pyruvate, 100 IU/ml IL‐2 
 
Vericyte medium 
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3.1.4 Inhibitors 
Name Target Source 
PD98059 MAPK pathway Cayman Chemical, Ann Arbor, MI, US 
PP1 Src-family tyrosine kinases Biomol, Hamburg, Germany 
Syk Inhibitor IV SYK Calbiochem/Merck Millipore, Billerica, MA, US 
U73122 PLC Biomol, Hamburg, Germany 
U73343 Inactive analog of U73122 Biomol, Hamburg, Germany 
Wortmannin PI3K Biomol, Hamburg, Germany 
Concanamycin A V-H+-ATPase Sigma-Aldrich, St. Louis, MO, US 
Bafilomycin A1 V-H+-ATPase BioViotica, Göttingen, Germany 
(+)-/(-)-Blebbistatin Myosin IIA  Cayman Chemical, Ann Arbor, MI, US 
GM6001 (Ilomastat) Collagenase (MMP) US Biological, Swampscott, MA, US 
Batimastat MMPs Calbiochem/Merck Millipore, Billerica, MA, US 
Piceatannol Syk family kinases Cayman Chemical, Ann Arbor, MI, US 
Cytochalasin D Disruption of F-actin filaments US Biological, Swampscott, MA, US 
Jasplakinolide Induces actin polymerization Enzo Life Sciences, Lörrach, Germany 
Nocodazole Promotes tubulin 
depolymerization 
Calbiochem/Merck Millipore, Billerica, MA, US 
Paclitaxel Promotes assembly of 
microtubules, prevents 
microtubule depolymerization 
Cell Signaling Technology, Danvers, MA, US 
Calyculin A PP2A, PP1 Calbiochem/Merck Millipore, Billerica, MA, US 
Okadaic Acid PP1, PP2A, PP3 Cayman Chemical, Ann Arbor, MI, US 
AEB071 (Sotrastaurin) Protein kinase C (PKC) Axon Medchem, Groningen, Netherlands 
PKCθ pseudosubstrate  
   inhibitor, myristoylated 
PKCθ Calbiochem/Merck Millipore, Billerica, MA, US 
U0126 MEK1/2 Cayman Chemical, Ann Arbor, MI, US 
SB202190 p38 MAP kinase Biomol, Hamburg, Germany 
Sodium azide  Mitochondrial oxidative 
phosphorylation 
Carl Roth, Karlsruhe, Germany 
Cycloheximide Inhibits protein synthesis in 
eukaryotes (translocation step) 
Sigma-Aldrich, St. Louis, MO, US 
(S)-MG132 Proteasome, inhibits NFκB 
activation 
Cayman Chemical, Ann Arbor, MI, US 
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3.1.5 Kits 
Name Source 
ATPlite – Luminescence ATP Detection Assay System PerkinElmer, Rodgau, Germany 
Dynabeads Untouched human NK cell Kit Invitrogen/LifeTechnologies, Darmstadt, Germany 
P3 primary cell 4D Nucleofector X Kit L Lonza, Cologne, Germany 
PKH26 Red Fluorescent Cell Linker Kit for General 
Cell Membrane Labeling 
Sigma-Aldrich, St. Louis, MO, US 
PKH67 Green Fluorescent Cell Linker Kit for General 
Cell Membrane Labeling 
Sigma-Aldrich, St. Louis, MO, US 
 
3.1.6 Plasmids 
Name Source 
pBABEplus-CD48 Hoffmann et al., 2011 
 
3.1.7 Reagents 
Most reagents were purchased from Carl Roth (Karlsruhe, Germany), Sigma-Aldrich (Seelze, 
Germany), Merck/ Millipore (Darmstadt, Germany) and AppliChem (Darmstadt, Germany). 
 
Name Source 
Albumin Fraction V Carl Roth, Karlsruhe, Germany 
Annexin V-PE/Annexin V-FITC BD Biosciences, San Jose, CA, US 
BD FACS Permeabilizing Solution 2 BD Biosciences, San Jose, CA, US 
CellTracker Violet BMQC Molecular Probes/LifeTechnologies, Darmstadt, Germany 
Clear blue X ray films, CL-Xposure Pierce/Thermo Fisher Scientific, Rockford, IL, US 
Chromium-51 Hartmann Analytic, Braunschweig, Germany 
Immobilon-P-PVDF membrane EMD Millipore Corporation, Billerica, MA, US 
Ionomycin Calbiochem/Merck Millipore, Billerica, MA, US 
Lymphocyte Separation Medium (LSM) 1077 PAA Laboratories, Cölbe, Germany 
Monensin Sigma-Aldrich, St. Louis, MO, US 
Non-fat dry milk powder Saliter, Obergünzburg, Germany 
NuPAGE Gels Invitrogen/LifeTechnologies, Darmstadt, Germany 
Paraformaldehyde Sigma-Aldrich, St. Louis, MO, US 
Precision Plus Protein™ All Blue Standards Bio-Rad Laboratories, Munich, Germany 
Phorbol 12-myristate 13-acetate (PMA) Sigma-Aldrich, St. Louis, MO, US 
Puromycin Calbiochem/Merck Millipore, Billerica, MA, US 
Recombinant human interleukin (IL)-15 PAN Biotech, Aidenbach, Germany 
SuperSignal West Pico and Dura Substrate Pierce/Thermo Fisher Scientific, Rockford, IL, US 
0"!%25"$&"*.&0%!6'.+!
 
 28 
Name Source 
Tecin (recombinant human interleukin (IL)-2) NIH Cytokine Repository 
WesternBright Sirius HRPO substrate Advansta, Menlo Park, CA, US 
 
3.1.8 siRNAs 
All siRNAs were purchased from Dharmacon/Thermo Fisher Scientific (Rockford, IL, US). They 
were resuspended to 20 µM in ddH2O according to the manufacturers protocol. After determination 
of the concentration using a NanoDrop 2000 spectrometer (Thermo Fisher Scientific, Rockford, IL 
US), the RNA was aliquoted and stored at -20 °C. 
 
Name Target Sequence 
Control siRNA (non-targeting siRNA #1)  not available 
siRNA PKRCQ (ON-TARGET plus, #09) human PKC! GCUCGCUGCUUAAGAGAUA 
siRNA PKRCQ (ON-TARGET plus, #10) human PKC! CCACACAGAUUUAAAGUCU 
siRNA PKRCQ (ON-TARGET plus, #11) human PKC! GCAAUUCACAAGAAGUGUA 
siRNA PKRCQ (ON-TARGET plus, #12) human PKC! CCACAAGGAGAGAUUCAAA 
siRNA PRF1 (ON-TARGET plus, #06) human perforin 1 UGGAAGGGCUCACGGACAA 
siRNA PRF1 (ON-TARGET plus, #07) 
 
human perforin 1 GGUCAGUGCGGCUGGAUUU 
siRNA PRF1 (ON-TARGET plus, #08) 
 
human perforin 1 CUACAGUUUCCAUGUGGUA 
siRNA PRF1 (ON-TARGET plus, #09) human perforin 1 GGCCAUCACACCUCCAUUA 
 
3.1.9 Flow chamber system 
Name Source 
Cover glasses Paul Marienfeld GmbH & Co. KG, Lauda-Königshofen, Germany 
Microscope slides Paul Marienfeld GmbH & Co. KG, Lauda-Königshofen, Germany 
Discofix® 3-way Stopcock B. Braun Melsungen AG, Melsungen, Germany 
Female/male connectors Ibidi GmbH, Martinsried, Germany 
µ-Slide VI 0.4 Ibidi GmbH, Martinsried, Germany 
Silicone Tubing 1.6 mm ID Ibidi GmbH, Martinsried, Germany 
Y Tube Fitting 1.6 mm Ibidi GmbH, Martinsried, Germany 
Syringe (luer; 50 mL and 2 mL) B. Braun Melsungen AG, Melsungen, Germany 
Perfusor secura FT B. Braun Melsungen AG, Melsungen, Germany 
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3.2 Methods 
3.2.1 Cellular biology 
Cell culture 
All cells were grown at 37 °C and 5 % CO2 in a humidified incubator under sterile conditions. Cell 
lines were split on a regular basis every two to three days. Cell culture flasks were exchanged every two 
weeks. Cells were frozen in FCS containing 10 % DMSO at -75 °C and stored in liquid nitrogen. Cell 
lines were thawed on a regular basis. FCS, donor horse serum and human serum were heat inactivated 
by incubation at 56 °C for 30 min prior to use. 
 
NK cell isolation 
Peripheral blood mononuclear cells (PBMC) were isolated from whole blood via density 
centrifugation over LSM solution. NK cells were purified from PBMC using a NK cell negative 
selection kit (Invitrogen) according to the manufacturers protocol. The purity was controlled using 
flow cytometry. 90 to 99 % of the cells were CD3- CD56+ NKp46+. 
 
NK cell culture with feeder cells 
Isolated NK cells were resuspended in culture medium supplemented with 5 ng/mL recombinant 
human IL-15 and 200 IU/mL recombinant human IL-2, mixed with irradiated (30 Grey) JY feeder 
cells (5x105 cells/mL) and plated in 96-U-well plates at densities ranging from 1x106 to 2x106 
cells/mL. This step was repeated after seven days of culture. Growing cultures were expanded 1:1 in 
culture medium. Cells were used for experiments two to five weeks after isolation. 
 
NK cell culture in Vericyte medium 
Purified NK cells were cultured in Vericyte medium (Medicyte) according to the manufacturers 
protocol. Briefly, they were seeded at 1x106 cells/mL in 96-U-well plates. Medium was exchanged 
three days after purification and subsequently split to 1x106 cells/mL if the density exceeded 
2x106 cells/mL. Otherwise the medium was exchanged latest after seven days. For experiments cells 
were used between two and five weeks after purification. 
 
Inhibitor pre-treatment 
Where indicated, NK cells or target cells where pre-treated with inhibitors at 5x105 to 1x106 cells/mL 
in culture medium at 37 °C/5 % CO2 for 30 to 60 min. The inhibitors were present in the assay in the 
indicated concentrations. For experiments with concanamycin A and bafilomycin A1 NK cells were 
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pre-treated for 3 h at 37 °C/5 % CO2. The cells were washed in medium before application in the 
experiments. These inhibitors were not present during the assays. 
 
Cell lysis 
Pelleted cells were resuspended in ice-cold 0.5 % triton X-100 lysis buffer at a density of 
2x107 cells/mL and incubated on ice for 20 min. The lysates were clarified by centrifugation at 
20,000 x g/4 °C for at least 15 min, transferred to fresh tubes and stored at -20 °C. 
 
Chromium-release assay 
To determine the cytotoxic capacity of NK cells, 51Cr-release assays were performed in 96-U-well 
plates. In assays with titrations of inhibitors (log2), human primary IL-2 activated NK cells were used 
at an E:T 5:1 or 4:1. In assays where inhibitor concentrations were kept constant the E:T was titrated 
(log2) starting at 20:1, 10:1 or 5:1. Target cells grown to mid-log phase were labeled at 5x105 in 
100 µL medium with 100 µCi 51Cr (3.7 MBq) for 1 h at 37 °C. Subsequently, cells were washed twice 
and resuspended to 5x104/mL in medium. 5,000 cells/well were used in all assays. Spontaneous release 
was measured using target cells incubated in medium alone. The maximum release was determined by 
incubating the target cells in 1 % triton X-100 during the time of the assay. In assays with inhibitor 
present, background toxicity by the treatment was controlled by incubating target cells in the highest 
concentration of the inhibitor, as well as the respective solvent control without NK cells. All samples 
were done in triplicates. Plates were incubated for 4 h at 37 °C, 5 % CO2. Supernatant was harvested 
and 51Cr release was measured in a WIZARD2 Automatic Gamma Counter (PerkinElmer, Rodgau, 
Germany). Percent specific lysis was calculated as !!"#!$%&!'()*!!"#"$%"! !!"#$%&$'#(!!!"#"$%"!!!"#$!%!!!"#"$%"! !!"#$%&$'#(!!!"#"$%"!  x 100.! 
 
Flow cytometry 
Cell staining for flow cytometry 
Cell staining was performed in 96-V-well plates. 1x105 to 2x105 cells were resuspended in 50 µL cold 
fluorescence-activated cell sorting (FACS)-buffer. The respective amount of fluorophore-conjugated 
antibody was added and the samples were incubated for 20 min on ice. After washing, the cells were 
resuspended in FACS-buffer and analyzed on a BD FACSCalibur. Results were evaluated using the 
FlowJo software from Tree Star Inc.!!!
Cell viability assay  
Cell viability assays were performed in 96-V-well plates. 50,000 cells were resuspended in 25 µL 1 x 
annexin-V binding buffer. 1.25 µL/sample annexin-V were added and the cells incubated for 15 min 
in the dark at room temperature. As positive control 0.2 µL 2 % triton X-100 was added to the 
0"!%25"$&"*.&0%!6'.+!
 
 31 
reaction. The staining reaction was stopped by addition of 200 µL cold 1 x annexin-V binding buffer 
per sample and placement on ice. The amount of annexin V+ cells was determined immediately using 
the FACSCalibur. The increase in Annexin V+ staining compared to untreated cells was evaluated 
using the FlowJo software from Tree Star Inc. According to background fluorescence of various 
inhibitors, either FITC- or PE-conjugated annexin V was used. !
Degranulation assay (Alter et al., 2004) 
Degranulation assays were performed in 96-V-well plates. Target cells were grown to mid-log-phase. 
5x104 human primary IL-2-activated NK cells were mixed with 1x105 target cells at a final volume of 
100 µL Medium? PBS?. Where mentioned, inhibitors or respective solvent controls were added to the 
reaction. 1.25 µL anti-LAMP1 or IgG control were added to the samples. Depending on the auto-
fluorescence of the applied inhibitors, FITC- or PE/Cy5-conjugates antibodies were used. As positive 
control for degranulation NK cells were treated with 1 µg/mL ionomycin and 10 nM PMA. Samples 
were centrifuged at 20 x g/room temperature for 2 min and incubated for 2 h to 4 h at 37 °C/5 % 
CO2. The cells were centrifuged at 400 x g/4 °C for 5 min, resuspended in 50 µL FACS-buffer per 
reaction and stained for 20 min on ice with either CD56-PE or IgG-PE. After washing, the samples 
were resuspended in cold FACS-buffer, kept on ice and analyzed immediately using a FACSCalibur. 
The amount of CD107a+ cells of the CD56+ NK cell population was evaluated using the FlowJo 
software from Tree Star Inc. NK cells incubated without targets cells were used to determine 
spontaneous and inhibitor-induced degranulation. 
 
Cell labeling for flow cytometry-based conjugation and detachment assays 
For all conjugation and detachment assays, cells were labeled with PKH Fluorescent Cell Linker Kits 
for General Cell Membrane Labeling (Sigma-Aldrich) according to the manufacturers protocol with 
minor changes. Cells were washed twice in PBS and resuspended to 1x107 cells/mL in diluent C. An 
equal volume of 2x10-6 to 4x10-6 M dye working solution in diluent C was added and the samples 
incubated for 5 min at room temperature. The reaction was stopped by addition of an equal amount of 
fetal calf serum and incubation for 1 min. The samples were washed three times in culture medium 
and incubated at 6x105 to 8x105 cells/mL at 37 °C/5 % CO2.  Prior to use cells were counted, washed 
and resuspended to the required density. 
For some assays target cells were labeled with CellTracker Violet BMCQ (Molecular Probes) 
according to the manufacturers protocol with a final dye concentration of 5 µM. Briefly, cells were 
resuspended at 1x106 to 1x105 cells/mL in pre-warmed staining solution (CellTracker Violet diluted in 
IMDM without any supplements) and incubated at 37 °C for 30 min.  Subsequently, cells were 
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washed and incubated for another 30 min in pre-warmed IMDM without supplements, washed once 
and applied in assays. 
 
Flow cytometry-based conjugation assay (based on (Burshtyn, 2010)) 
Conjugation assays were performed in 1.5 mL tubes. To distinguish the cell populations, effector cells 
were usually labeled with PKH26 Fluorescent Cell Linker and target cells with PKH67 Fluorescent 
Cell Linker. 5x104 human primary IL-2-activated NK cells were mixed with 1x105 target cells at a 
final volume of 100 µL medium, centrifuged at 20 x g/room temperature for 1 min and incubated at 
37 °C. The reaction was stopped at various time points between 0 to 60 min by vortexing and addition 
of 100 µL 4 % paraformaldehyde. The samples were kept on ice and analyzed immediately using the 
BD FACSCalibur. The amount of NK cells engaged in conjugates compared to the total amount of 
NK cells was evaluated using the FlowJo software from Tree Star Inc. 
 
Conjugate decay assay with non-adherent target cells (based on (Culley et al., 2009)) 
To distinguish the cell populations, effector cells were usually labeled with PKH26 Fluorescent Cell 
Linker and target cells with PKH67 Fluorescent Cell Linker. 5x105/mL NK and 1x106/mL target 
cells in assay medium (IMDM, 10 % FCS, 1 % penicillin/streptomycin) were mixed, centrifuged at 
20 x g/room temperature for 3 min and transferred to 37 °C for 30 min (pre-coincubation period). 
Pre-coincubated mixed cells were diluted 1:25 in assay medium and aliquoted. The samples were 
incubated rotating at 37 °C. The reactions were stopped after 0, 10, 20, 40, 60 and 90 min by 
vortexing and addition of an equal amount 4 % paraformaldehyde. After incubation at room 
temperature for 10 min, samples were centrifuged at 400 x g/4 °C for 5 min, resuspended in FACS-
buffer and analyzed on a BD FACSCalibur. As controls 4x104/mL single NK and 8x104/mL target 
cells were pre-incubated separately and combined at the point of dilution, aliquoted and treated as the 
pre-mixed samples. Control reactions were stopped 0, 40 and 90 min after dilution. The amount of 
NK cells engaged in conjugates compared to the total amount of NK cells was evaluated using the 
FlowJo Software from Tree Star Inc. The half-life of the conjugates was determined using the formula 
for a one-phase exponential decay: 
 
 
! ! !" !!"!!"#$%#&!"#$!!  
 
 
 
τ - Half-life [min] 
ln - Natural logarithm 
Y - Amount of remaining conjugates  [%] 
Span - Span between the exponentially determined maximum and 
minimal amount of remaining conjugates 
Plateau - Exponentially determined minimal amount of remaining 
conjugates [%] 
K - Rate constant [min-1] 
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Conjugate decay assay with adherent target cells 
The conjugate decay assay with adherent target cells was performed in 6-well plates. As targets HeLa-
CD48 cells were used. Target cells were seeded at 0.75x105 cells/well 1 d prior use, to obtain a 
confluent layer. Before the assay, medium was removed, cells were washed once in complete culture 
medium and 3x106 to 5x106 NK cells in 1 mL were added to each well. The plate was centrifuged for 
3 min at 20 x g/room temperature and incubated for 30 min at 37 °C/5 % CO2. To remove all 
unbound NK cells, medium was harvested, wells washed twice with complete culture medium and the 
plate centrifuged upside down covered with a second 6-well plate at 400 x g/5 min/room temperature. 
Harvested and washing media were combined and kept on ice. Fresh medium was added and the 
samples incubated with agitation at 37 °C/5 % CO2 on a "Sunflower" 3D Mini–Shaker (BioSan, Riga, 
Latvia). This harvesting and washing-step was repeated after 30, 60 and 90 min. For each time point 
the harvested supernatants and washing media were combined and kept on ice. After the last 
harvesting step the number of the cells in the combined media was determined, the samples 
centrifuged at 400 x g/4 °C for 5 min and resuspended to 2x106 cells/mL. Cells were stained for flow 
cytometry in a 96 well V-bottom-plate. For each staining reaction 50 µL NK cell suspension were 
used. Cells were analyzed for expression of various surface receptors using PE-conjugated antibodies: 
2B4, CD69, CD158e, DNAM1, EB6, GL183, NKG2D, NKG2A, NKG2C, NKp30, NKp44 or 
NKp46. To each staining reaction anti-CD56-FITC (NK cell specific marker) and anti-LAMP1-
PE/Cy5 (detection of NK cell degranulation) were added. IgG-isotype controls for all fluorophores 
were applied in a separate staining. The samples were stained for 20 min on ice in the dark, washed 
once, resuspended in FACS-buffer and analyzed on a FACSCalibur. The surface expression of the 
receptors was evaluated using the FlowJo Software from Tree Star Inc. and compared with the 
expression before contact to the target cells. 
 
Determination of intracellular ATP level (ATPlite-kit) 
Cellular ATP levels were determined using the ATPlite-kit from PerkinElmer (Rodgau, Germany) 
according to the manufacturers protocol. A black 96-flat clear bottom well plate was used. For each 
treatment a background control, containing medium with inhibitor alone, was added. The 
luminescence was detected using an Infinite M200 Pro (Tecan Group Ltd., Männedorf, Germany). 
 
siRNA transfection 
NK cells were transfected with 40 pmol of the respective siRNA using the Amaxa P3 primary cell 4D 
Nucleofector X Kit, program DK-100 according to the manufacturers protocol. 3x106 NK cells per 
reaction were pelleted at 90 x g for 10 min, gently resuspended in P3 primary cell solution containing 
siRNA, transferred to a cuvette and transfected. The samples were immediately transferred to 
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37 °C/5 % CO2 and incubated for 3 min. 250 µL pre-warmed RPMI without any supplements were 
added and the samples incubated for another 10 min at 37 °C/5 % CO2. Cells were transferred to 
1.15 mL pre-warmed IMDM per sample (supplemented with 10 % (v/v) human serum, 1 % (v/v) 
non‐essential amino acids, 1 % (v/v) sodium pyruvate) in a 24-well plate. After 20 h medium was 
exchanged and recombinant human IL-2 added to a final concentration of 100 IU/mL. Cells were 
used for experiments 48 h post transfection. To determine the efficiency of the transfection at least 
3.5x104 cells were lysed and analyzed using western blot.  
 
3.2.2 Microscopy 
Time lapse microscopy 
Time lapse experiments were done in µ-slideVI luer (Ibidi). HeLa-cells were seeded at 6x105/mL one 
day prior use and incubated at 37 °C/5 % CO2. NK cells were labeled with PKH26 Fluorescent Cell 
Linker and resuspended at 2x106 cells/mL in degased pre-warmed phenolred-free assay medium. All 
parts of the flow chamber system (except for the pump) were equilibrated to 37 °C 24 h before use. As 
medium for the assay phenol red-free IMDM supplemented with 10 % (v/v) FCS and 1 % (v/v) 
penicillin/streptomycin (Gibco/Invitrogen/LifeTechnologies, Darmstadt, Germany) was used, which 
was degased for at least 30 min and warmed to 37 °C directly before use. The medium in the reservoirs 
of the flow chamber was gently aspirated and the medium in the chamber exchanged for the degased 
assay medium. The syringes (B. Braun Melsungen AG, Melsungen, Germany) were connected via 
1.6 mm ID silicon tubing (Ibidi GmbH, Martinsried, Germany) and 3-way Stopcocks (B. Braun 
Melsungen AG, Melsungen, Germany) to the flow chamber. During set up all remaining air bubbles 
were removed before the system was attached to the flow chamber. The flow chamber was placed in a 
climate chamber providing 37 °C/5 % CO2. The first images were acquired before addition of the NK 
cells, then NK cells were added and allowed to attach for 30 min. After this, a flow with 32.5 mL/h 
was applied using a Perfusor secura FT pump (B. Braun Melsungen AG, Melsungen, Germany). The 
resulting shear stress was 0,96 dyn/cm2. Images were acquired about every 75 sec with an IX 81 
motorized inverted microscope (Olympus, Hamburg, Germany) and analyzed using the ImageJ 
software from the National Institute of Health (Bethesda, MD, US). 
 
3.2.3 Protein biochemistry 
SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
Cell lysates were mixed with 5x reducing sample buffer, and boiled for 5 min at 95 °C. The samples 
were cooled on ice and were shortly centrifuged.  A maximum of 20 µL lysate and 5 µL precision blue 
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standard (BioRad) were loaded onto a 10 % or 4–12 % BisTris-NuPAGE gels (LifeTechnologies) and 
separated for 1 h 15 min at 150 V in 1 x MOPS buffer. 
For analysis of perforin expression with the anti-human perforin antibody Pf344 (MabTech), samples 
were analyzed under non-reducing, denaturating conditions.  
 
Western blot 
Following SDS-PAGE proteins were transferred to a polyvinylidene difluoride (PVDF) membrane 
(Millipore), (activated with methanol,) for 1.5 h at 200 mA in Western blot transfer buffer. After 
transfer, membranes were incubated in blocking buffer for at least 1 h at room temperature, washed 
three times in PBST and incubated with primary antibody over night at 4 C. Subsequently, the 
membrane was washed three times in PBST/NaCl and incubated with the appropriate horseradish-
peroxidase (HRPO)-conjugated secondary antibody (1:5,000-1:20,000 in blocking buffer) for at least 
1 h at room temperature. After another 3 times of washing in PBST, the membrane was developed 
using SuperSignal West Pico/Dura or WesternBright Sirius HRPO substrate and X-ray films. X-ray 
films were scanned with a Perfection V700 Photo (Epson, Munich, Germany) using the Universal 
Silver Fast Launcher (LaserSoft Imaging AG, Kiel, Germany) and analyzed using ImageJ software 
from the National Institute of Health (Bethesda, MD, US). 
 
3.2.4  Statistical analyses 
Statistical analysis was performed using Prism 4.0 (GraphPad Software Inc., San Diego, CA, US). 
Values < 0.05 were esteemed significant and marked by a single asterisk.  ** denotes values  < 0.01; *** 
< 0.001, ns marks not significant values. If not otherwise indicated a paired one-tailed student’s t-test 
was applied. 
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4. Results 
4.1 Establishment of a flow cytometry-based assay system to determine the NK-
tumor cell conjugate half-life 
In NK cell research a strong focus lies on processes leading to activation and the thereby initiated 
effector functions. The steps between target cell encounter and the lytic hit are fairly well understood 
(Orange, 2008; Mace et al., 2014). In contrast, the subsequent process of the detachment of the NK 
from the target cell has not been evaluated specifically so far. This is one of the reasons why 
approaches to study this event are limited. Some groups used microscopy to visualize the whole event 
of NK-target cell interaction but did not analyze the detachment as such (Mace et al., 2012; 
Choi&Mitchison, 2013; Vanherberghen et al., 2013). 
Therefore, we established an assay system based on an approach described by Culley and colleagues 
(2009) to characterize this process by using flow cytometry (Culley et al., 2009). Primary human IL-2-
activated NK cells and K562 as susceptible target cell line were membrane labeled with PKH dyes. 
This labeling allows analysis of living cells without disturbing their function. The labeled cells were 
mixed and coincubated for 30 min in a small volume to allow conjugate formation (Fig. 4.1 A). This 
period will subsequently be referred to as “pre-coincubation”. After this time the conjugate formation 
was still in a log-phase, with more conjugates forming than decomposing, but with a considerable 
amount of conjugates already generated. In general about 25 to 40 % if NK cells were engaged in 
conjugates at this time point. (data not shown). To stop the formation of new conjugates the samples 
were diluted 1:25, aliquoted and rotated for up to 90 min (Fig. 4.1 C). This treatment successfully 
prevented the formation of new conjugates. Separately incubated effector and target cells, that were 
mixed at the point of dilution showed a background of only 1 to 2 % NK cells in conjugates (data not 
shown). 
 
 
Fig. 4.1: Scheme for the detachment 
assay. (A) PKH26-labeled human IL-2-
activated NK cells were mixed 1:2 with 
PKH67-labeled K562 cells and pre-
coincubated for 30 min. (B) Samples were 
diluted 1:25 and aliquoted. If indicated 
inhibitors were added at this point. 
(C) Diluted samples were rotated for up 
to 90 min, before the reaction was 
stopped by vortexing and fixation with 
PFA.  
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Before fixation with PFA the samples were briefly vortexed to separate loose NK:K562 contacts that 
were not considered as functional conjugates. The membrane label in different colors allowed 
distinguishing NK (FL-2+) from target cell (FL-1+) populations in a scatter plot analysis. NK:K562-
conjugates appear as double positive events. The amount of NK cells that are engaged in conjugates 
was determined as percentage of all NK cells in the assay (Fig. 4.2 A). To compare the data the value 
was normalized to the amount of NK cells in conjugates at the time point of dilution after 30 min pre-
coincubation and plotted against the time. The values on the x-axis represent the time elapsed after 
dilution. To evaluate the data and determine the half-life of the conjugates the data were analyzed 
with a non-linear regression using the model of a one phase exponential decay (Fig. 4.2 B). With a 
coefficient of determination (R2) of usually >0.98, this model reflects the primary data best. The half-
life describes the time after which half of the originally formed conjugates did separate (indicated in 
figure 4.2 B by the dotted line). The pre-coincubation period is not included in this time since the 
actual age of the conjugates at the point of dilution could be between 0 to 30 min. In our system the 
observed half-life was 47.0 ± 11.8 min, with donor dependent differences since the experiments were 
done with primary human NK (Fig. 4.2 C). 
 
 
 To determine factors influencing the detachment various inhibitors against different targets were 
applied in the assay. To not interfere with the formation of the conjugates the inhibitors were added at 
the point of dilution (Fig. 4.1 B). DMSO was used as solvent for most of the inhibitors used. Thus, 
we checked if it is affecting the detachment. Treatment with DMSO did not alter the half-life as 
shown in figure 4.2 C (45.1 ± 14.1 min). 
 
 
Fig. 4.2: Gating strategy and determination 
of the conjugate half-life. (A) In a scatter plot 
PKH26-labeled NK cells were discriminated 
from PKH67-labeled K562. The double 
positive population represents NK:K562-
conjugates. The gate was set on all events 
positive for PKH26 and the number of NK 
cells engaged in conjugates determined as 
percent of all NK cells in the assay. This was 
done for samples after 30 min pre-
coincubation (0 min), and at 10, 20, 40, 60 
and 90 min after dilution. (B) The percentage 
of NK cells in conjugates for the various time 
points was normalized to the value after 
30 min pre-coincubation, plotted as 
percentage of conjugates remaining against 
the time and fitted as a one phase exponential 
decay (representative example). (C) The half-
life of conjugates formed by untreated (n=24) 
and DMSO-treated NK cells (n=38).  
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To further inquire the influence of the set up, the assay was performed with varying E:T ratios and 
pre-coincubation times. The half-life changed only slightly if the E:T ratios were 1:1, 1:2 or 1:3 
(34.6 ± 6.5 min, 38.4 ± 10.9 min or 37.3 ± 10.4 min, resp.). For an E:T of 1:5 the half-life of 
48.1 ± 9.6 min was in general increased to a certain extent compared to the lower ratios (Fig. 4.3 A). 
Changing the pre-coincubation time to 20 min instead of 30 min did also not alter the half-life 
(53.8 ± 33.8 min vs. 50.7 ± 37.7 min) (Fig. 4.3 B). 
4.2 Availability of new targets in close proximity accelerates the decay of existing 
conjugates 
Recently, Choi and Mitchison (2013) proposed a model of “kinetic priming”, suggesting that the NK 
cell remains attached to a previous target until a new one induces the detachment (Choi&Mitchison, 
2013). A mechanism that would allow sustained signaling in the NK cell resulting in an accelerated 
cytolytic function. To test this in our assay system, an exceeding amount of new targets was added at 
the point of dilution (initial K562:fresh K562 = 1:200). To distinguish the subsequently added targets 
from the initial ones, they were labeled in a third color (CellTracker violet). Since agitation prevented 
the formation of new conjugates, the samples were incubated motionless after dilution. In figure 4.4 a 
representative example is shown. Without addition of fresh target cells and without rotation the decay 
was strongly decelerated (t1/2 = 102.7 min) compared to the control with rotation (t1/2 = 36.5 min). If 
fresh targets were added at the point of dilution and the samples were not rotated, the detachment was 
almost as fast as in the condition without fresh targets with rotation (t1/2 = 40.4 min) and the control 
with addition of fresh targets with rotation (t1/2 = 39.6 min). Simultaneously, the amount of NK cells 
in conjugates with new target cells increased over time, if the samples were kept motionless, indicating 
that the addition of fresh susceptible targets increases the decay of the “old” conjugates in favor of the 
formation of “new” conjugates with the freshly added NK cells. In the control condition with rotation 
the formation of conjugates occurred only at late time points and to a minimal extent. In an additional 
control the freshly added target cells were fixed with PFA before application in the assay. This 
 
Fig. 4.3: Minor changes in the E:T ratio and the 
duration of the pre-coincubation time do not alter 
the half-life. (A) Half-life of NK:K562-conjugates 
determined in detachment assays with (A) different 
E:T ratios (1:1, 1:3: n=3; 1:2, 1:5: n=5) or (B) 
varying pre-coincubation times (E:T=1:2; n=4). (A, 
B) Graphs show mean ± SD. Paired two-tailed 
students t- test; ns=not significant. 
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treatment successfully prevents formation of conjugates (data not shown). In the condition with 
addition of fresh fixed target cells, the decay was comparable to the condition with no addition of fresh 
target cells and without rotation. Considering the dilution of initially added susceptible targets in the 
freshly added unsusceptible targets, the probability that a NK cells encounters another one of these 
while engaged in a conjugate is comparably small. This indicates that the decelerated decay during 
motionless incubation without addition of fresh targets is not due to an equilibrium of decay and 
formation of new conjugates with the initial targets, but rather to sustained attachment. Similar results 
were obtained for two more donors (data not shown).  
Thus, in agreement with the hypothesis of Choi and Mitchison, availability of a new target in close 
proximity induced detachment form the previous conjugate, possibly by reorientation of the cell 
polarity. 
 
 
4.3  Establishment of a microscopy–based flow chamber system to visualize NK 
cell detachment from target cells 
In addition to analyzing the detachment in a flow-cytometry-based approach, we aimed to visualize 
the process using live-cell imaging. This allowed investigation of the detachment on the single-cell 
level. We established a flow-chamber system with HeLa cells as susceptible targets. Therefore, HeLa 
cells were grown in the flow chamber at a low density and NK cells were added in an exceeding 
amount to enable the formation of a high number of conjugates. After 30 min pre-coincubation time, 
the flow of medium with 35 mL/h was started. The induced shear stress was about 1 dyn/cm2, 
commonly used for flow chamber assays (Gonzales&Wick, 1996; André et al., 2000; Tager et al., 
2003). It is slightly lower than the level of shear stress in small blood vessels (Balagopalan et al., 2011). 
For comparison the shear stress found in arteries is about 100 dyn/cm2 and in veins 5 dyn/cm2 (Pries et 
al., 1995). The flow was applied to prevent the formation of new conjugates by detaching NK cells 
 
Fig. 4.4: Availability of fresh target cells accelerates the decay of pre-formed NK:K562-conjugates. In the decay assay 
conditions with addition of fresh viable (v) or fixed (f) K562 cells at the point of dilution were compared to the standard 
condition without addition of fresh target cells (øK562) The samples were either incubated motionless (ørot) or rotating 
(w rot). (A) Decay curves for the five compared conditions. (B) Formation of conjugates with freshly added targets. 
Time point 0 resembles the point of dilution. 
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and to break loose cell-cell contacts that might not be mature synapses. The cells were observed for 
about 60 min after initiation of the flow with images taken every 74 sec. NK cells that were not 
washed away directly after starting the flow were followed until they detached from the target cell or 
until the end of the observation time. If multiple NK cells encountered a target and if these could not 
be distinguished, they were excluded from the analysis. Similarly, NK cells that were attached to a 
target and washed away still connected to the target were also excluded. 
 
 
Figure 4.5 A shows an example of a NK:HeLa cell contact. Two NK cells were attached to the target 
at the beginning of the observation. One (#2) was washed away already after about 6 min, whereas the 
other NK cell (#1) remained attached. The target rounded after about 16 min and was washed away 
after 59 min, breaking the contact to the NK cell. For two different donors the decrease of the amount 
of NK cells attached to HeLa cells is displayed over time in figure 4.6 (left graphs). Additionally, the 
half-life of the cell-cell interactions was determined using the fit for a one-phase-exponential-decay 
(right graphs). 67 NK:HeLa cell contacts observed for donor 1 had a half- life of 28.1 min. 66 NK 
cells of donor 2 were in contact with HeLa cells, and the determined half-life was 49.5 min. As seen 
in the flow cytometry-based decay assay, there are donor-dependent differences for the half-life. 
However, the overall time frame for the detachment seemed to match with the flow cytometry-based 
assay. Interestingly, as described in the literature (Onfelt et al., 2004; Roda-Navarro et al., 2004; 
Chauveau et al., 2010; Comerci et al., 2012), we also observed formation of nanotube-like structures 
between NK and HeLa cells (Fig. 4.5 B). 
 
 
 
 
 
Fig. 4.5: Life-imaging of NK cell detachment 
from HeLa cells under flow conditions. HeLa 
cells were grown in flow chambers, and NK cells 
(red) pre-coincubated for 30 min. A medium 
flow was started and images taken every 74 s. (A) 
One exemplary NK:HeLa cell contact, that was 
followed for about 60 min. NK cells are indicated 
by black arrows. (B) Examples for nanotube-like 
structures formed between NK and HeLa cells. 
(A, B) Scale bar = 40 pixel. 
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Fig. 4.6: Analysis of NK cell 
detachment from HeLa-target cells 
observed via life cell-imaging. For 
two different donors (A, B) the 
amount of NK cells connected to 
HeLa cells was determined and 
plotted against the observation time 
(left curves). The data were fitted 
with a one-phase exponential decay 
(right curves) and the half-life 
determined.  
 
4.4 Surface receptor expression patterns of detached NK cells 
Various NK cell receptors, e.g. 2B4 or NKG2D, were shown to be down-modulated after antibody-
mediated cross-linking or ligand binding (Sandusky et al., 2006; Roda-Navarro&Reyburn, 2009). 
Diminishing interaction with the target cell is discussed to be one mechanism leading to detachment.  
 
 
To gain access to recently detached NK cells that certainly had target cell contact, a detachment assay 
with adherent target cells was established. NK cells were added to a confluent layer of HeLa cells 
transfected with CD48, the ligand for 2B4 (HeLa-CD48). The cells were incubated for 30 min to 
allow conjugate formation (Fig. 4.7 A). After this pre-coincubation all unbound NK cells were 
removed and the formed conjugates further incubated under three-dimensional rotation (Fig. 4.7 B) to 
prevent formation of new conjugates by detached NK cells. Subsequently, NK cells that detached in 
the following 30 min, between 30 and 60 min and between 60 and 90 min were harvested (Fig. 4.7 C) 
and analyzed for their surface expression pattern compared to NK cells before target cell contact. To 
compare different donors the relative fluorescence intensity (RFI) was determined for each time point 
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Fig 4.7: Scheme of the detachment assay with 
adherent target cells. NK cells were added to a 
confluent layer of HeLa-CD48 cells and pre-
co-incubated for 30 min. After removal of 
unbound NK cells the conjugates were 3D-
rotated for up to 90 min at 37 °C. Detached NK 
cells were harvested after 30 min, between 30 to 
60 min and between 60 to 90 min after removal 
of the unbound NK cells and analyzed for 
surface expression of various receptors using 
flow cytometry. 
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and receptor. Figure 4.8 shows the summary of the obtained data for various receptors. CD56 as NK 
cell marker was used to exclude HeLa cells from the analysis. CD11a as part of the lymphocyte-
function associated antigen (LFA)-1 was analyzed to inquire possible changes in the integrin surface 
level. CD69 as early activation marker provides information about the activation status of the NK 
cells. CD107a serves as a marker for degranulation indicating induced effector functions by target cell 
contact. In addition to the natural cytotoxicity receptors NKp30, NKp44 and NKp46 the activating 
receptors 2B4, DNAM-1, and NKG2D were analyzed. As inhibitory receptor, NKG2A that forms a 
heterodimer with CD94 was included in the survey. Additionally, the expression of CD158 a, b1/b2 
and e was determined. Since these were expressed very weakly or not at all they were excluded from 
the analysis. 
 
 
Fig. 4.8: The surface expression pattern of various receptors is altered after detachment. Relative fluorescence intensity 
(RFI) of various NK cell receptors before addition to HeLa-CD48 target cells, on NK cells removed after 30 min pre-
coincubation, additional 30 min, 30 to 60 min and 60 to 90 min. (n=3). PCI = pre-coincubation. paired two-tailed 
students t-test (!< 0.05) 
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Interestingly, all molecules except for CD11a and CD107a showed a lower RFI after 30 min pre-
coincubation compared to the corresponding untouched NK cells. This is possibly due to the handling 
of the cells during the assay. When analyzing NK cells after detaching from the target cells we found 
that amount of CD56 and CD11a increased back to the levels of untouched cells, whereas the 
expression of NKp44 and DNAM-1 did not change after the initial decrease. As described in 
literature, expression of 2B4 and NKG2D was significantly reduced by target cell contact. NKp46, 
although not significantly, did show a similar trend, indicating that the same mechanism might also be 
true for this receptor. The third group of receptors CD69, NK30 and NKG2A were higher expressed 
on late detaching NK cells. Again this was rather a trend then a significant change. The altered surface 
expression pattern of these receptors could be a sign of down-modulation of the receptors after 
activation. Alternatively, since the experiments were conducted with bulk NK cells, the differences 
could be due to diverse features of distinct subpopulations. 
The increase in CD107a surface expression that was already detectable 30 min after pre-coincubation 
indicates that the NK cells were in functional contacts with the target cells, which induced 
degranulation most probably leading to lysis.  
 
4.5 The Role of PKC! on the stability of the NK cell aIS 
Studies on the immunological synapse between CD4+ T cells and antigen presenting cells (APCs) 
revealed an importance of PKC! for the breakage of the synapse (Sims et al., 2007). In YTS cells 
PKC! was found to phosphorylate WASp-interacting protein (WIP) after target cell contact and 
thereby enable the recruitment of myosin II A and actin to the WIP-WASp-multi protein complex 
(Krzewski et al., 2006). In mouse NK cells, Tassi and colleagues (2008) found a necessity of PKC! for 
ITAM-mediated IFN"-secretion (Tassi et al., 2008). To assess if PKC! is also important for 
destabilizing the aNKIS we interfered with this signaling molecule using specific inhibitors and RNAi 
technology. First, AEB071 (also called sotrastaurin), a PKC specific inhibitor with increased 
selectivity for PKC! (Ki = 0.22 nM) was applied (Evenou et al., 2009). In a 51chromium release assay 
the effects of the inhibitor on the cytotoxic potential of NK cells was evaluated. Inhibition of PKCs 
led to a dose-dependent reduction of the lysis of K562 target cells (Fig 4.9 A). At an E:T ratio of 5:1 
the treatment with 250 nM AEB071 reduced the lysis by 15.1 ± 7.5 % compared to the solvent 
control DMSO. Increasing the concentration to 500 nM led to a stronger reduction of 48.7 ± 6.0 %  
(Fig. 4.9 A). Although the cytotoxicity was impaired, the higher concentration of the inhibitor did not 
affect the formation of conjugates (Fig. 4.9 B). In contrast to the data for CD4+ T cells, inhibition of 
PKC! did not changed the detachment of NK cells. No significant difference between the half-life of  
2%+1$!+!
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 conjugates of AEB071-treated NK cells compared to the solvent-treated NK cells was observed 
(Fig 4.9 C). 
 
 
Since AEB071 might also inhibit other PKC isoforms as PKC# (Ki = 0.95 nM) or PKC&I 
(Ki = 0.64 nM) the more selective myristoylated pseudosubstrate inhibitor was tested to verify the 
obtained data. For 3 of 4 donors the lysis of K562 cells was reduced by about 27 % after treatment of 
the NK cells. One donor did not respond to the treatment, indicating donor-dependent differences in 
the responsiveness to the treatment (Fig. 4.10 A). Compared to the inhibition induced by the two 
different AEB071 concentrations the effect of the pseudosubstrate inhibitor is intermediate, suggesting 
that higher concentrations of AEB071 might already inhibit other isoforms than PKC! alone. In a third 
approach, PKC! was knocked down by specific siRNAs targeting the PKRCQ mRNA. Four 
oligonucleotides were tested either alone or in different combinations. The most effective 
combinations were #9/#10 or a mix of all four, leading to a reduction of PKC! protein by 80 % 
(Fig. 4.10 B). To test the influence of the siRNAs on other isoforms, exemplarily the expression of 
 
Fig 4.9: Inhibition of PKCs by AEB071 (sotrastaurin) reduces the cytotoxicity but does not affect formation or stability 
of conjugates. NK cells were pre-treated for 1 h with 250 nM ( ) or 500 nM AEB071 (") or DMSO (#) as solvent 
control. The inhibitor concentration present during the pre-incubation was kept constant during the assays with K562 
cells as target cells. (A) Standard 51chromium release assay. The curve of one representative example (left) and the 
quantification of the experiments with three different donors (right) are shown as mean ± SD. (B) Conjugate formation 
assay. The curves represent the mean values ± SD of 3 different donors. (C) Conjugate decay assay. Decay curves of one 
representative example and quantification of 3 different donors are shown as mean ± SD. (p=0.3699) 
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PKC# was determined. It was not altered by the transfection (Fig. 4.10 B). Surprisingly, the reduction 
of PKC! expression did not affect the cytotoxicity towards K562 target cells (Fig. 4.10 C). 
 In summary, these data indicate that PKC! itself has limited if any influence on target cell lysis, 
whereas other isoforms might be required for full efficiency of NK cell effector functions. However, 
for the formation and maintenance of NK-target cell conjugates PKC! and most probably other 
isoforms as PKC# or PKC& did not seem to be essential. 
 
4.6 Signaling pathways 
4.6.1 Early but not late sustained activating signaling is required for conjugate stability 
The formation of an aNKIS is strongly depending on signaling pathways induced by the interaction of 
activating NK cells receptors with their respective ligands. The formation of a functional NK cell 
synapse is considered to occur in distinct and tightly regulated steps (Orange et al., 2003; Orange, 
2008). The pathways induced by triggering activating receptors are complex and partly redundant 
(Watzl&Long, 2010). Additionally, signaling via the integrin LFA-1 contributes to the activation 
(Long et al., 2013). Principle players in the signaling cascades are for instance protein tyrosine kinases 
(PTKs), e.g. Src- and Syk-family kinases that activate various molecules as SLP76, Vav1, PLC" or 
WASp, inducing gene transcription and cytoskeletal remodeling. Additionally, triggering PI3K leads 
to activation of MAP kinase pathways cumulating in granule polarization and exocytosis (Vyas et al., 
2002). The question arose, if these signaling molecules involved in the formation also are required for 
the maintenance of NK-target cell conjugates. Hence, we applied various specific inhibitors in the 
decay assay. Adding the reagents at the point of dilution guarantees an undisturbed formation of 
conjugates. The course of the decay would give information about the role of the signaling molecules 
for the stability of the conjugates.  
 
Fig. 4.10: Specific inhibition of PKC! by its pseudosubstrate or knock-down of the kinase by RNAi does not alter the 
cytotoxicity towards K562 target cells. (A) NK cells were pre-treated for 30 min with 25 µM myristoylated PKC! 
pseudosubstrate (PS) before addition of K562 target cells. The inhibitor concentration was kept constant during the assay. 
(E:T=5:1; n=4, mean ± SD). (B and C) NK cells were transfected with either control siRNA (20 pmol) or a mix from 
PKCRQ siRNAs #9 and #10 (10 pmol each) or a mix from PKCRQ siRNAs #9, #10, #11 and #12 (5 pmol each). 48 h 
post transfection one part of the cells was lysed for western blot analysis (B). Standard 51chromium release assay. One 
representative experiment is shown as mean ± SEM (n=2). 
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 47 
 Initially, early signaling events as Src- and Syk-family kinases, as well as PLC" and PI3K were 
targeted. The effect of the inhibitors on the effector function of the NK cells was tested in a 
cytotoxicity assay. All inhibitors, except for wortmannin (PI3K), led to a significant reduction of the 
cytotoxicity (Fig. 4.11 A), emphasizing the importance of these signaling events for NK cell function. 
When these inhibitors were applied in the detachment assay, all of them, including wortmannin, 
significantly reduced the half-life of the conjugates.  
 
 
In Fig. 4.11 B-F exemplary decay curves are shown. Inhibition of Src family kinases, as Lck, Fyn, Src 
or Hck, by PP1 led to an average reduction of the half-life by 77 % from 52.7 ± 15.5 min to 
11.3 ± 6.2 min compared to the solvent control (Fig. 4.11 B). Likewise, interfering with Syk-family 
 
Fig. 4.11: Disruption of early signaling events impairs the cytolytic potential of NK cells and accelerates the decay of 
NK:K562-conjugates. Specific inhibitors targeting various signaling events were employed in standard 4 h 51chromium 
release (A) and conjugate decay assays (B-F). (A) NK cells were pre-treated for 30 min with the respective inhibitor before 
addition of K562 target cells at an E:T ratio of 5:1. Values are shown as mean ± SD. (n=4, for PP1 and wortmannin n=5). 
(B-F) Inhibitors were added at the point of dilution after 30 min pre-coincubation. For each treatment a representative 
conjugate decay curve and the quantification for 3 to 4 different donors is shown. (!< 0.05; !! < 0.01). 
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kinases by piceatannol or Syk inhibitor IV also decreased the conjugate stability. Piceatannol, which 
has a slightly broader spectrum of targets at a concentration of 100 µM (Syk and Lyn) reduced the 
half-life by about 40 % from 53.7 ± 8.3 min to 32.7 ± 11.3 min. Syk inhibitor IV shows a higher 
selectivity for Syk without affecting other Syk- or also Src-family kinases. The reduction of the half-
life by 40 % was comparable to the effect caused by piceatannol treatment (53.7 ± 8.3 min to 
32.4 ± 13.3 min compared to DMSO; Fig. 4.11 C and D). These data indicate that Src- and Syk-
kinases are indispensable for conjugate stability. Furthermore, targeting PLC", which induces Ca2+ 
flux and PKC activation, by the inhibitor U73122 decreased conjugate stability even stronger than 
inhibition of Src- and Syk-kinases. The half-life was reduced by 70 % from 59.5 ± 12.2 min to 
16.2 ± 11.1 min compared to the inactive analog U73343 (Fig. 4.11 D). Inhibition of PI3K by 
wortmannin, although it did not show any effect on the cytotoxicity (Fig. 4.11 A), reduced the 
conjugate half-life by 50 % from 52.7 ± 15.5 min to 26.6 ± 10.4 min (Fig. 4.11 E). 
 Taken together these data indicate a pivotal role of ongoing early signaling in the NK cell not only for 
cytotoxicity but also for the maintenance of conjugates. 
 
 
Signaling molecules that act further downstream of PI3K such as mitogen-activated protein kinase 
(MAPK) cascades are crucial for polarization and degranulation of the NK cells (Vyas et al., 2002). 
 
Fig. 4.12: Late activating signaling events are required for full cytolytic capacity of NK cells, but not for the maintenance 
of NK:K562-conjugates. (A) NK cells were pre-treated for 30 min with the MAPK inhibitors PD98059, U0126 or 
SB202190 before addition of K562 target cells at an E:T of 5:1. The inhibitor was present during the 4 h standard 
51chromium release assay. The values are shown as mean ± SD. (PD98059: n=3, U0126: n=2; SB: n=4). (B-D) The 
inhibitors were added to a standard conjugate decay assay at the point of dilution in the indicated concentration. For each 
treatment a representative decay curve and the quantification of experiments with three different donors are shown. (!< 
0.05; !! < 0.01).  
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Inhibition of MEK1/2 by PD98059 or U0126 reduced the cytotoxicity by 46 % to 67 %, respectively. 
But if the inhibitors were applied in the decay assay no effect on the half-life was observed 
(DMSO: 52.4 ± 12.4 min, PD98059: 61.1 ± 16.3 min, U0126: 66.0 ± 27.7 min; Fig. 4.12 B, C). The 
serine-threonine kinase p38 has been reported to play a role for cytokine production under certain 
conditions (Mainiero et al., 2000) and to have a regulatory function in target cell lysis (Chini et al., 
2000). Inhibition of p38 by SB202190 did not influence the lysis of target cells or the stability of 
conjugates. The half-life (60.1 ± 0.3 min) was unchanged compared to the solvent control DMSO 
(61.0± 1.2 min; Fig. 4.12 D). 
In summary, the data suggest that signaling events further downstream of PI3K are required for full 
effector functions of NK cells but not for their potential to remain in conjugates. 
 
4.6.2 Inhibitory signaling 
 Triggering of inhibitory NK cell receptors that contain a cytoplasmic immunoreceptor tyrosine-based 
inhibition motif (ITIM) leads to recruitment of the tyrosine phosphatases SHP-1 and SHP-2. SHP-1 
in turn dephosphorylates Vav1 and thereby interrupts initial steps of NK cell activation (Watzl&Long, 
2010). Since sustained early activating signaling is required for conjugate stability, the question arose if 
phosphatases might induce detachment by ceasing activation steps. NSC87877 and 119901 were 
described as inhibitors of the phosphatases SHP-1 and SHP-2 (Chen et al., 2006; Wahle et al., 2007). 
But when tested, we did not observe any changes in NK cell cytotoxicity (data not shown).  
 
 
Therefore, the general tyrosine phosphatase inhibitor pervanadate was used (Huyer et al., 1997).  By 
irreversibly oxidizing the catalytic cysteine residue of protein tyrosine-phosphatases it induces an 
 
 
Fig. 4.13: Inhibition of 
tyrosine phosphatases by 
pervanadate affects 
cytotoxicity of NK cells and 
their ability to form 
conjugates with target cells. 
(A) NK cells resuspended in 
PBS or assay medium (CTL) 
were treated for 10 min with 
various pervanadate 
concentrations, washed, lysed 
and probed for tyrosine 
phosphorylation (4G10) and  
actin   as  a  loading   control.  
 
(B) NK cells were pre-treated for 10 min, washed and mixed with K562 cells 
at various E:T in a 4 h standard 51chromium release assay. (C) NK cells were 
pre-treated with pervanadate, washed and subsequently applied in a conjugate 
formation assay with K562 target cells. (B, C) Values are shown as mean ± 
SD. (n=3). 
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 50 
increase of overall tyrosine phosphorylation. Pervanadate was titrated to determine the lowest 
concentration that still induces increased tyrosine phosphorylation in assay medium without affecting 
the NK cell viability. The NK cells were treated for 10 min and analyzed for tyrosine phosphorylation. 
Untreated IL-2-activated NK cells do not show detectable background phosphorylation. The highest 
concentration of 200 µM pervanadate led to an increased phosphorylation in both PBS and assay 
medium. But this amount might be toxic and affect the viability of the cells indicated by the weaker 
actin signal. Lower concentrations starting from 12.5 µM down to 3.13 µM also increased tyrosine 
phosphorylation without affecting the actin level, indicating that these concentrations are still effective 
without being toxic (Fig. 4.13 A). Since the lowest concentration of 3.13 µM still increases the level of 
tyrosine phosphorylation, it was used for the following experiments. Additionally, the concentration 
was further reduced to 1.56 µM. In a cytotoxicity assay against K562 cells these concentrations reduce 
the lysis in a dose-dependent manner (Fig. 4.13 B). Because long-term treatment of the NK cells with 
pervanadate induces apoptosis (data not shown), the NK cells were pre-treated, washed and applied in 
a conjugate formation assay without addition of pervanadate. Inhibiting tyrosine phosphatases strongly 
reduced the ability of the NK cells to form conjugates compared to untreated cells (Fig. 4.13 C). Thus, 
since tyrosine phosphatases in general are required for normal activation and function of NK cells their 
role in detachment could not be determined in the assay system used here. 
 
Besides phosphorylation of tyrosine residues, a number of signaling molecules, e.g. Akt or Erk, are 
regulated via serine- or threonine phosphorylation. Treatment of NK cells with the S/T phosphatase 
inhibitor calyculin A was shown to reduce NK cell-mediated cytotoxicity (Bajpai and Brahmi, 1994). 
The S/T phosphatase PP2A was found to negatively regulate IL-2 signaling in NK cells (Ross et al., 
2010). Other than that, not many details about S/T phosphatases in NK cells are known. We targeted 
S/T phosphatases with two inhibitors. Okadaic acid has a broader spectrum interfering with PP1 
(IC50 = 10-50 nM), both isoforms of PP2A (IC50 = 0.5 nM) and PP3 (IC50 = 4 nM). Calyculin A is 
targeting only PP1 (IC50 = 2 nM) and PP2A (IC50 = 0.5-1 nM). Titration of okadaic acid in a 
cytotoxicity assay led to inhibition of the target cell lysis only at higher concentrations (Fig. 4.14 A). 
In the conjugate decay assay, inhibitor treatment increased the half-life significantly, but only slightly 
(EtOH: 35.8 ± 2.1 min, okadaic acid: 38.3 ± 2.4 min) (Fig. 4.14 B). Calyculin A instead showed a 
stronger inhibitory effect on lysis and conjugate half-life. The half-life was reduced by about 52 % 
from 35.8 ± 2.1 min to 17.0 ± 1.8 min (Fig. 4.14 C, D). Since calyculin A is not inhibiting PP3 and 
the IC50 values for PP2A are comparable for both inhibitors, the effect seen with calyculin A is most 
likely due to the inhibition of PP1. This indicates a major role for this S/T phosphatase for the 
stability of conjugates and for the cytolytic function of NK cells. 
 
2%+1$!+!
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4.7  Energy level 
 In NK and T cells cytoskeleton dynamics, cell migration and also the granule exocytosis mediated by 
motor proteins as myosin II A are ATP-dependent processes (Samstag, 2003; Andzelm et al., 2007; 
Ilani et al., 2009; Sanborn et al., 2009 2011; Sanborn et al., 2011 2011; Kumari et al., 2012). 
However, Davis and colleagues showed that KIR-induced clustering of HLA-C in inhibitory NK cell 
synapses is not affected by depletion of intracellular ATP (Davis et al., 1999). The role of ATP for the 
aNKIS is not well understood yet. Therefore, the question arose if the intracellular energy level 
influences the detachment process. Azide is a potent inhibitor of ATP by interrupting mitochondrial 
respiration (Palmieri&Klingenberg, 1967; Fei et al., 2000).  
We first analyzed the effect of sodium azide treatment on the intracellular ATP-level. After 2 h 
treatment with 50 mM sodium azide the ATP level in the cells was reduced by 63.8 ± 3.5 % 
(Fig. 4.15 A). The capability of ATP-depleted NK cells to form conjugates with K562 target cells was 
moderately decreased (Fig. 4.15 B). Interestingly, when azide was added directly before mixing with 
the target cells the effect was comparable to the inhibition observed when the NK cells were pre-
treated for 2 h. A similar trend was seen for the lysis of K562 target cells. Under both conditions, 2 h 
pre-treated and not pre-treated NK cells, showed an equivalently reduced cytotoxicity (Fig. 4.15 C).  
 
Fig. 4.14: Inhibition of serine-
threonine phosphatases by 
calyculin A but not by okadaic 
acid decreases the cytolytic 
potential of NK cells and the 
stability of NK:target cell 
conjugates. (A, C) NK cells 
were pre-treated for 30 min with 
the respective inhibitor before 
addition of K562 target cells at 
an E:T of 5:1. The inhibitor 
concentration was kept constant 
during the 4 h standard 
51chromium release assay.  
Values are shown as mean ± SD. 
(n=3; paired two-tailed students 
t-test). (B, D) The inhibitors 
applied in the conjugate decay 
assay at the point of dilution. 
For each treatment a 
representative decay curve and 
the quantification of the 
experiments with 3 different 
donors are shown. (!< 0.05; !! 
< 0.01) 
! "! #! $! %! &!!
!
"'
'!
('
&!!
&"' )*+,
+-./.012.10/23"'!2456
*07829704:
;
21
<4
=>
?.
*8
@2A
87
.0
40
4?
!"#
$
%&
'()
*'+
,-.
-/0
1-,
23
1
45
51
65
011
045
7
-89
:)
+;+
)-
'(
8+8
!"#
$
#%
&'
&()
*+)
('*
,-.
/*0
12
/
-.
./
3.
4//
4-.
5
*67
8)
(9(
)*
:;
6(6
Ca
lyc
uli
n A
 
(10
 nM
) 
A B 
C D 
! "! #! $! %! &!!
!
"'
'!
('
&!!
&"' )*+,
-./012/345657&!5489
*3:;5<:34=
>
51
?4
@2
A.
*;
B5C
;:
.3
43
4A
!"#$ #%&'&()*+)('*,-./*012
/
-.
./
3.
4//
" 4
5-
*67
(0
8
!"#$ %&'()*'+,-.-/01-,23
1
45
51
65
011
" 0
74
-89
+,
:
** 
* 
EtO
H 
Ok
ad
aic
 ac
id 
(25
0 n
M)
 Et
OH
 
Ok
ad
aic
 ac
id 
(25
0 n
M)
 
EtO
H 
EtO
H 
Ca
lyc
uli
n A
 
(10
 nM
) 
** 
ns 
2%+1$!+!
 
 52 
 To determine the influence of the ATP level on the stability of conjugates sodium azide was applied 
in the conjugate decay assay. As for conjugate formation and cytotoxicity studies, the NK cells were 
either pre-treated before mixing with the target cells or the azide was added after 30 min pre-
coincubation at the point of dilution. The pre-treated NK cells formed less conjugates, which is in 
consistence with the data for conjugate formation (Fig. 4.15 B). Interestingly, already after 10 min the 
decay curves for both conditions are nearly superimposable (Fig. 4.15 D). This trend was seen for all 
donors tested, indicating that the effect triggered by azide occurred very rapid. The stronger reduction 
of the half-life for conjugates with pre-treated NK cells results from the different percentages of NK 
cells in conjugates at time point 0. Compared to H2O treated NK cells (41.5 ± 12.3 min), the 
conjugates with pre-treated NK cells showed a reduction of the half-life by 58 % to 17.0 ± 2.9 min. 
Addition of azide at the point of dilution diminished the half-life by 76.6 % to 9.6 ± 2.4 min 
(Fig. 4.15 E). These data indicate that effector functions like cytotoxicity as well as formation and 
maintenance of NK-target cell conjugates also depend on ATP. 
 
Fig. 4.15: Depletion of intracellular ATP by sodium azide impairs the potential of NK cells to form and maintain 
conjugates and reduces the lysis of K562 target cells. NK cells were either treated with 50 mM sodium azide or H2O as 
solvent control. (A). The relative amount of ATP after 2 h treatment was determined using the ATPlite assay system. (B) 
Conjugate formation by treated NK cells with K562 target cells. NK cells were either pre-treated for 2 h or the inhibitor 
added at the time point of mixing with target cells. In both conditions the inhibitor concentration was present during the 
assay. (C) Pre-treated or not pre-treated NK cells were applied in a 4 h standard 51chromium release assay against K562 
target cells. Sodium azide was present in the assay. (A-C) Values are shown as mean ± SD. (n=3) (D-F) In the conjugate 
decay assay either pre-treated NK cells were applied with the inhibitor present during the assay or sodium azide was 
added at the point of dilution to untreated conjugates. One representative experiment is shown in (E) and (D), and the 
quantification of experiments with three different donors in (F). (!< 0.05). 
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4.8 Cytoskeleton dynamics 
4.8.1 A dynamic actin cytoskeleton is indispensable for conjugate stability 
The formation of the aNKIS is strongly depending on actin cytoskeleton rearrangement, which is 
considered to occur at the beginning of the effector stage (Orange, 2008; Mace et al., 2014). These 
rearrangements also play an important role for regulation and transit of lytic granules in the process of 
degranulation (Brown et al., 2011; Rak et al., 2011). It was shown that treatment with the actin 
cytoskeleton inhibitors cytochalasin D (cyto D) and jasplakinolide (jaspla) interfered with conjugate 
formation and reduced the cytotoxicity of NK cells (Cooper, 1987; Bubb et al., 1994; Orange et al., 
2002; Wulfing et al., 2003; Rak et al., 2011). Therefore, we tested both substances in our system. Cyto 
D is a destabilizing reagent, leading to depolymerization of F-actin (Flanagan&Lin, 1980; 
Goddette&Frieden, 1986; Cooper, 1987). In contrast jasplakinolide stabilizes F-actin by preventing 
its degradation (Bubb et al., 1994; Bubb, 2000; Holzinger, 2009). NK cells were pre-treated for 
30 min with the respective inhibitor before addition of the K562 target cells. Both treatments nearly 
abolished the cytolytic capacity (Fig. 4.16 A) and strongly affected the stability of the conjugates. 
Addition of cyto D to the conjugates at the point of dilution reduced the half-life by 89 % from 
63.9 ± 25.1 min to 6.6 ± 1.5 min compared to the solvent control DMSO (Fig. 4.16 B). Similarly, use 
of jasplakinolide decreased the half-life to 7.7 ± 3.5 min (88 %; Fig. 4.16 C). This shows, in 
accordance with literature, that a dynamic cytoskeleton is indispensible for the function of NK cells 
and the maintenance of conjugates. 
 
 
 
 
Fig. 4.16: Interfering with actin cytoskeleton dynamics by treatment with 
cytochalasin D or jasplakinolide abolishes NK cell cytotoxicity and induces 
rapid detachment from K562 target cells. (A) NK cells were treated for 30 min 
with cytochalasin D, jasplakinolide or DMSO before addition of K562 target 
cells at an E:T of 4:1 in a 4 h 51chromium release assay. Values are shown as 
mean ± SD. (n=4). Cytochalasin D (B) or jasplakinolide (C) were added at the 
point of dilution in a conjugate decay assay. DMSO served as solvent control. 
Representative examples for the decay curves and the summary of experiments 
with three different donors are shown. (!< 0.05; !!!< 0.001 ) 
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4.8.2 Tubulin 
The degranulation process is not only strongly dependent on actin rearrangement but is considered to 
also depend on the microtubule cytoskeleton. The convergence of lytic granules to the microtubule 
organizing center (MTOC) and the recruitment to the synapse occur along microtubules (Katz et al., 
1982; Stinchcombe et al., 2006; Banerjee et al., 2007). Here, we used two inhibitors to interfere with 
microtubules. Nocodazole destabilizes microtubules and induces their depolymerization (Vasquez et 
al., 1997). Paclitaxel on the contrary stabilizes microtubules (Amos&Lowe, 1999). Treatment of the 
NK cells with these inhibitors caused a minor, although for nocodazole (9.3 %) significant, reduction 
of the cytotoxicity towards K562 target cells (Fig. 4.1.5 A). If added to the standard decay assay with 
K562 cells at the point of dilution, only nocodazole decreased the half-life of the conjugates (DMSO: 
29.3 ± 11.6 min, nocodazole: 18.1 ± 6.4 min; reduction: 41 %; Fig. 4.17 B), whereas paclitaxel seemed 
not to affect the conjugate stability (DMSO: 47.1 ± 10.1 min, paclitaxel 47.3 ± 17.3 min; Fig. 4.17 C). 
Thus, the interference with the microtubule cytoskeleton affects the cytotoxicity of NK cells only 
slightly. Considering that depolymerizing the microtubules by nocodazole reduced the half-life, 
whereas stabilizing by paclitaxel does not, indicates a necessity of formed microtubules for the 
maintenance of conjugates. 
 
 
 
Fig. 4.17: Blocking microtubules by nocodazole or paclitaxel only slightly affects NK cell 
cytotoxicity and NK:K562-conjugate stability. (A) NK cells were treated for 30 min 
with nocodazole, paclitaxel or DMSO before addition of K562 target cells at an E:T of 
4:1 in a 4 h 51chromium release assay. Values are shown as mean ± SD. (n=4). 
Nocodazole (B) or paclitaxel (C) were added at the point of dilution in a conjugate decay 
assay. DMSO served as solvent control. Representative examples for the decay curves 
and the summary of experiments with three different donors are shown. (!< 0.05; ns = 
not significant) 
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4.9 MMP/ADAM inhibitors 
Metalloproteinases as MMPs (matrix metalloproteinases) and ADAMs (a disintegrin and 
metalloproteinases) located at the cell surface play a pivotal role in immunology. For instance, they 
have been described to cleave CD16 and thereby regulate receptor down-modulation (Peruzzi et al., 
2013; Romee et al., 2013; Zhou et al., 2013; Parsons et al., 2014). Additionally, these enzymes are 
found to play a role in cancer. As matrix-degrading enzymes they are implicated in invasion processes. 
Furthermore, they were also described to shed activating ligands, which then bind to NK cells 
rendering them hyporesponsive (Groth et al., 2011). As described for CD16, metalloproteinases 
might target other activating NK cell surface receptors and thereby regulate the interaction with the 
target cell. Therefore, we tested two inhibitors of MMPs and ADAMs to evaluate their impact on 
conjugate stability. Batimastat targets the MMPs-1, -2, -3, -7 and -9 as well as ADAM-17 and -8 
with increasing IC50 value. GM6001 targets MMPs-8, -9, -1, -2 and -3. Neither of the inhibitors 
affected the cytotoxicity towards K562 cells, when the NK cells were pre-treated and the inhibitors 
were present in the assay (Fig. 4.18 A, C). If batimastat or GM6001 were applied in the conjugate 
decay assay with K562 cells at the point of dilution, no changes in the half-life were detectable 
(Fig. 4.18 B, C). Therefore, a role of these MMPs and ADAMs for NK cell cytotoxicity and the 
stability of NK:target cell conjugates most likely can be excluded. 
 
 
 
 
Fig. 4.18: Inhibition of metallo-
proteinases is not affecting NK cell-
mediated cytotoxicity nor 
NK:K562-conjugate stability. NK 
cells were treated for 30 min with 
batimastat (A), GM6001 (B) or 
DMSO before addition of K562 
target cells at an E:T of 4:1 in a 4 h 
51chromium release assay. Values 
are shown as mean ± SD. (n=3). In 
conjugate decay assays with K562 
target cells batimastat (B), 
GM6001 (D) or DMSO were 
added at the point of dilution. 
Representative examples for the 
decay curves and the summary of 
experiments with three different 
donors are shown. (ns = not 
significant). 
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4.10 Target cell survival 
The purpose of the formation of the activating NK cell synapse is the directed lysis of the target cell. 
An interesting emerging question was, which role the target cell death or survival plays for the kinetics 
of detachment of NK cells from target cells. It might be the death and the mechanisms that are 
induced during apoptosis, e.g. the phosphatidylserine flip or the loss of plasma-membrane integrity 
that induce detachment (Bouchier-Hayes et al., 2008; Wlodkowic et al., 2011). Thus, we tried 
different approaches to inhibit target cell lysis, or vice versa make the target cells more susceptible 
increasing the pace of lysis. To augment the sensitivity of K562 cells for NK cell-mediated lysis, the 
target cells were pre-incubated with the proteasome inhibitor Mg132. Unfortunately, the treatment 
did not induce the desired changes in the susceptibility towards NK cell cytotoxicity (data not shown). 
 
4.10.1 Prevention of target cell death 
In contrast to elevating the susceptibility of the target cells towards NK cell-mediated lysis, we aimed 
to prevent target cell death. If the detachment were influenced by target cell viability, a prolonged 
survival would suppress the detachment of the NK and thereby increase the conjugate half-life. A 
main mechanism of NK cells to induce target cell apoptosis is directed release of cytotoxic effector 
molecules, e.g. perforin and granzymes, into the synaptic cleft. Perforin forms pores in the target cell 
membrane inducing endocytosis as a rescue mechanism (Krzewski&Coligan, 2012). For the uptake of 
granzyme B different endocytosis mechanisms have been suggested. This includes fluid phase 
endocytosis, mannose 6-phosphate receptor-mediated endocytosis or heat shock protein 70 (HSP70)-
mediated endocytosis (Gross et al., 2003). In the target cell, granzyme B initiates via different 
pathways caspase-cascades cumulating in apoptosis of the target cell. To counteract this effect we used 
the pan-caspase inhibitor Z-VAD-FMK (Sedelies et al., 2008). Unfortunately, we did not see 
increased survival of the treated target cells (data not shown) and therefore did not follow this idea 
further. 
 
Instead of interfering with the induction of apoptosis in the target cell, we aimed to counteract the 
effector functions on the side of the NK cells. The first idea was to directly interfere with the release of 
the cytotoxic effector molecules, but prevention of NK cell-degranulation is a challenging task. One 
inhibitor known to reduce the amount of degranulation is blebbistatin. The compound inhibits 
myosin IIA, a motor protein that is required for the exocytosis of cytolytic granules in NK cells 
(Kovacs et al., 2004; Andzelm et al., 2007; Sanborn et al., 2009; Sanborn et al., 2011). To verify the 
inhibitory effect of blebbistatin on target cell-induced degranulation, the surface exposure of CD107a 
on treated NK cells after coincubation with K562 target cells was determined using flow cytometry. 
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 57 
The NK cells were pre-treated for 1 h with (-)-blebbistatin, the inactive enantiomer (+)-blebbistatin 
or the solvent control DMSO and the inhibitor present during the assays. A minor reduction of 
degranulation by 8 % was observed compared to the inactive analog (Fig. 4.19 A). The weak effect of 
the treatment could be due to the pre-activated status of the NK cells by culture with IL-2. 
Accordingly, the lysis of K562 target cells was reduced moderately by 28 % (Fig. 4.19 B). Since the 
NK cells were pre-treated, their ability to form conjugates was confirmed first. As shown in figure 
4.19 C the treatment did not alter the capacity to form conjugates compared to the inactive (+)-
blebbistatin or the solvent control. If NK cells pre-incubated with blebbistatin were applied in the 
conjugate decay assay the inhibition of myosin IIA increased the half-life of NK-target cell conjugates 
by 23 % from 40.8 ± 4.9 min for (+)-blebbistatin to 52.2 ± 4.10 min for (-)-blebbistatin (Fig 4.19 D). 
Myosin IIA is an ATPase, therefore we assessed if the treatment affects the cellular ATP level. The 
treatment did not change the level of ATP in the NK cells compared to the solvent control or the 
inactive analog (Fig. 4.19 E). Thus, reducing or inhibiting the degranulation of NK cells might 
increase the stability and thereby the half-life of NK:target cell conjugates. The reduced target cell 
death could be a possible cause for this observation. Even though, prevention of degranulation as such 
might also affect the detachment of NK cells from targets. 
 
 
Fig. 4.19: Reduction of NK cell degranulation by blebbistatin reduces the lysis of K562 target cells and increases the half-
life of NK:K562-conjugates. NK cells were pre-treated for 1 h with (-)-, (+)-blebbistatin or the solvent control DMSO. 
The inhibitor concentration was kept constant during the assays. K562 cells were used as targets. (A) CD107a (H4A3) 
surface expression after 4 h co-incubation with K562 cells (n=3). (B) Standard 4 h 51chromium release assay. (E:T=4:1; 
n=3) (C) Conjugateformation assay. (n=3) (D) Conjugate decay assay. One representative decay curve and the 
quantification of experiments with three different donors are shown. (E) Relative intracellular ATP level of treated NK 
cells were determined in an ATPlite assay. (n=3) (A-C, E) Values are shown as mean ± SD. (ns = not significant) 
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As that degranulation was only partially inhibited by blebbistatin, we alternatively aimed to target 
perforin to effectively prevent target cell death induction. A known and established inhibitor for 
perforin is concanamycin A (CMA) (Kataoka, 1994; Kataoka et al., 1996). CMA belongs to the 
plecomacrolide-defined class of macrolide antibiotics that targets vacuolar-type, proton-translocating 
ATPases (V-ATPases) and ATPases with phosphorylated states (P-ATPases) (Drose&Altendorf, 
1997). In eukaryotic cells V-H+-ATPase is expressed on the plasma membrane as well as on the 
membrane of intracellular compartments. By the ATP-dependent transport of protons from the inside 
of the compartment into the cytosol it maintains an acidic pH in the compartments, e.g. lytic granules 
(Kataoka et al., 1996). This acidic pH in turn is required by cathepsin L which cleaves perforin from 
its immature to its mature active form by removing a glycosylated carboxy-terminal peptide (Uellner et 
al., 1997; Konjar et al., 2010). In preliminary studies we tested the inhibitor for its capacity to reduce 
mature perforin. NK cells were treated for 3 h with the inhibitor or the respective solvent control 
DMSO. The expression of perforin was assessed by western blot using the monoclonal anti-
perforin1 antibody Pf344, which under denaturating, non-reducing conditions detects both isoforms. 
After treatment, although the inactive precursor was still detectable, the mature form was not, even 
after long exposure (Fig. 4.20 A, red rectangle). In the solvent control-treated samples the signal for 
the mature form is much stronger compared to the inactive form, indicating an exceeding amount of 
cleaved perforin. To test if the effect of CMA is reversible, we washed the cells after the treatment and 
incubated them for another 1 h and 4 h with or without the inhibitor present. In both conditions no 
mature perforin was detectable after 4 h. This shows that CMA treatment effectively and irreversibly 
induced to depletion of mature perforin in NK cells. To verify the results, we tested another 
monoclonal antibody against perforin in flow cytometry. We intracellularly stained treated cells with 
the anti-perforin antibody 'G9, which does not distinguish between the both forms. After 3 h 
treatment with CMA the amount of perforin was significantly reduced by 73 % compared to untreated 
and solvent control-treated cells. The remaining perforin signal could be the immature form that is 
detected by the 'G9 antibody. As control we stained for intracellular CD107a, another protein found 
in lytic granules. CD107a was still detectable after treatment and its expression rather increased 
slightly by 11 %. (Fig. 4.20 B). It was not clear whether the treatment with CMA leads to a passive 
reduction of mature perforin by preventing new formation and normal turnover, or if an active 
degradation process would be induced. Uellner and colleagues (1997) suggest, that the increased pH in 
the lytic granules by inhibition of V-H+-ATPase induces an accelerated degradation of cleaved 
perforin (Uellner et al., 1997). Therefore, we treated NK cells with cycloheximide (CHX) that 
interferes with protein biosynthesis and thereby prevents the formation of new perforin precursor. The 
amount of perforin after treatment for up to 4 h with two different concentrations was monitored 
using western blot technology. As shown in Fig. 4.20 C in the long exposure of the film, the amount 
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of immature perforin decreased with advancing incubation time if the cells are treated with either 
concentration compared to the untreated cells. In contrast, the amount of mature active form does not 
change. Thus, the reduction of mature perforin induced by CMA could not be simply due to normal 
protein turnover but is rather due to increased degradation. 
 
 
Fig. 4.20: Treatment of NK cells with concanamycin A (CMA) irreversibly depletes mature perforin. (A) NK cells were 
treated with CMA or solvent control for 3 h. Subsequently, the cells were washed and incubated for up to 4 h with (+) or 
without (-) the inhibitor present. Cell lysates were analyzed for perforin (prf1) expression (PF344). Actin levels were 
determined as loading control. Two different exposures for perforin detection are shown. (one representative example; n=3) 
(B) Intracellular staining for perforin (clone: 'G9; left) and CD107a (clone: H4A3, right) after 3 h CMA treatment. 
Histograms of one representative experiment are shown (solid grey - isotype control of CMA-treated cells; specific staining 
of DMSO- (black line) and CMA-treated (red-line) NK cells). Lower panels show the quantification of three different 
donors. (C) NK cells were treated for 4 h with cycloheximide (CHX) in the indicated concentrations. Cell lysates were 
analyzed as in (A) (one representative example; n=3). (D) Surface expression of various NK cell receptors after 3 h treatment 
with CMA or DMSO was determined via flow cytometry. The mean fluorescent intensities (MFIs) were normalized to 
untreated cells. (n=3) (E) Relative intracellular ATP level of treated NK cells were determined in an ATPlite assay. (n=3) (D, 
E) Values are shown as mean ± SD. 
 
Since the V-ATPases are implicated in various cell functions, e.g. vesicular transport, inhibition might 
have side effects besides depletion of mature perforin. To verify that the treated NK cells are still able 
to interact with target cells, we analyzed the surface expression of various receptors and the integrin 
alpha L chain (CD11a) that is part of the lymphocyte function-associated antigen-1 (LFA-1). 
20131209_CMA,Bafilo_prf1.jo Layout: CMA_DONOR 3
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Compared to untreated or DMSO treated controls neither of the tested proteins showed significant 
changes in the surface expression detected by flow cytometry (Fig. 4.20 D).  
The V-H+-ATPase requires ATP for its proton transport function. To investigate if inhibition of the 
V-ATPase function affects the cellular ATP level, relative amount of intracellular ATP was 
determined. After 3 h CMA treatment the amount of ATP did not change compared to the controls 
indicating that the V-ATPase function has only limited impact on the intracellular energy level 
(Fig. 4.20 E). 
 
 
 
 
 
Fig.: 4.21: Depletion of mature perforin by CMA 
prevents target cell lysis and dramatically increases the 
half-life of NK:target cell conjugates. NK cells were 
pre-treated for 3 h with CMA or DMSO as solvent 
control. The cells were washed before use in any assay 
and the assays were performed without the inhibitor 
present. As targets K562 cells were used. (A) Conjugate 
formation assay (n=3) (B) CD107a (H4A3) surface 
expression after 4 h coincubation with K562 cells. 
(E:T=1:2; n=3) (C) 4 h standard 51chromium release 
assay. (E:T=1:4; n=3) (D) Conjugate decay assay. The 
decay curve of one representative example and the 
quantification of experiments with three different 
donors are shown. (A-C) Values are shown as mean ± 
SD. (!!!< 0.001) 
 
Since the effects induced by treatment with CMA are irreversible, functional assays were performed 
with pre-treated NK cells without inhibitor present in the assays. Thereby, the inhibitor does not 
influence the target cells. The potential of the mature perforin-depleted NK cells to form conjugates 
with K562 target cells was unchanged compared to solvent control treated cells (Fig. 4.21 A). 
Additionally, the target cell-induced degranulation detected by CD107a surface exposure was not 
influenced by the treatment (Fig. 4.21 B). As expected the lysis of the target cells was nearly abrogated 
by the depletion of mature perforin (Fig. 4.21 C). The detachment of perforin-depleted NK cells from 
target cells was drastically decelerated. The half-life (125.8 ± 7.8 min) determined in the conjugate 
decay assay was strongly increased by 352 % compared to solvent control DMSO (35.8 ± 3.3 min) 
(Fig. 4.21 D). These data suggest that either the function of the vacuolar H+-ATPase is indispensable 
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for the detachment of NK cells from target cells or the survival of the target cells does prevent the 
dissociation of the conjugates. 
 
 
To validate the effect seen with CMA we tested another V-H+-ATPase inhibitor. Bafilomycin A1 is a 
member of the bafilomycin family that is structurally related to the class of concanamycins. As for 
CMA the effect of the treatment on the intracellular perforin level was determined first. NK cells were 
treated for up to 4 h and the perforin expression analyzed via western blot using the perforin-specific 
antibody Pf344. Compared to untreated and DMSO-treated cells the amount of mature perforin is 
 
Fig. 4.22: Treatment of NK cells with bafilomycin A1 reversibly depletes mature perforin and thereby reduces target cell 
lysis and increases NK:K562-conjugate stability. (A) NK cells were treated with bafilomycin or solvent control for 3 h. 
Subsequently, the cells were washed and incubated for up to 4 h with (+) or without (-) the inhibitor present. Cell lysates 
probed for perforin (prf1) expression (PF344) and actin as loading control. One representative experiment is shown (n=2) 
(B-F) NK cells were pre-treated with bafilomycin or DMSO, washed and applied in the assays without the inhibitor present. 
(B) Intracellular staining for perforin (clone: 'G9; left) and CD107a (clone: H4A3, right) after treatment. Histograms of one 
representative experiment are shown (solid grey - isotype control of bafilomycin-treated cells; specific staining of DMSO- 
(black line) and bafilomycin-treated (red-line) NK cells). Lower panels show the quantification of three different donors. (C) 
Relative intracellular ATP level in treated NK cells determined in an ATPlite assay (n=3) (D) Conjugate formation assay. 
(n=3) (E) 4 h standard 51chromium release assay. (E:T=1:4; n=3) (F) Conjugate decay assay. The decay curve of one 
representative example of three experiments with different donors is shown. (C-E) Values are shown as mean ± SD. 
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strongly reduced already after 2 h incubation and after 3 h it is not detectable anymore. If the inhibitor 
was removed and the cells incubated further without inhibitor the signal slightly increased again 
indicating that the observed effect is partially reversible (Fig. 4.22 A). Via intracellular flow cytometry 
a reduction of the perforin level by 74 % was detected. This was comparable to the effect seen by 
CMA-treatment (Fig. 4.20 B; Fig. 4.22 B). However, the level of intracellular CD107a was 
unchanged. As seen for the CMA-treatment inhibiting the V-H+-ATPase has no influence on the 
intracellular ATP-level (Fig. 4.22 C). In the further experiments NK cells were pre-treated for 3 h and 
the assays were performed without the inhibitor present. The potential of the treated NK cells to form 
conjugates was not altered by the treatment compared to the DMSO-treated NK cells (Fig. 4.22 D). 
The cytotoxicity of bafilomycin A1-treated cells was reduced, but not fully abolished as seen for the 
CMA treatment (Fig. 4.21 C). This could be due to the restored mature perforin seen in western blot 
analysis after 4 h of incubation without the inhibitor. As seen for CMA the detachment of the NK 
cells from the target cells was dramatically decelerated (Fig. 4.22 F), for two of three experiments the 
half-life could not be determined since there was almost no decay of conjugates (data not shown). The 
observation that the detachment was decelerated this much although target cell lysis was not 
completely blocked, indicates that the effect seen is rather due to V-ATPase inhibition rather than to 
prevented target cell death. 
 
To prove, if the effect seen is due to loss of mature perforin, we attempted to knock down the protein 
by RNA interference. We tested four different oligonucleotides targeting perforin 1-mRNA either 
separately or in various combinations and determined the amount of perforin after 48 h via western 
blot. Unfortunately, reduction of mature perforin was not achieved by any of the treatments (data not 
shown). 
 
To interfere with the intracellular perforin level without affecting the vacuolar H+-ATPase we used 
the ionophore monensin. Because of its effects on intracellular trafficking the compound is widely 
used for intracellular retention of proteins, e.g. cytokines (Tartakoff, 1983). As ionophore it allows 
H+-exchange between intracellular compartments, e.g. acidic lytic granules and the cytosol and thereby 
leads to an increased pH in these compartments. The result, similar to the effect induced by CMA or 
bafilomycin A1, causes inhibition of important enzymes as the ones that are required for perforin 
cleavage. So far the effect of monensin on the perforin level has not been studied yet, therefore we first 
titrated the inhibitor and detected the level of intracellular perforin via western blot using the anti-
perforin antibody Pf344. Already after 1 h treatment the amount was reduced in a dose-dependent 
manner. The concentration of 8.6 µM monensin effectively depleted mature perforin without affecting 
he amount of the immature precursor (Fig. 4.23 A). Additionally, the reversibility of perforin- 
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treduction was investigated. Pre-treated NK cells were incubated for another 24 h without the 
ionophore present and samples taken every 4 h. As seen before, after 1 h treatment the mature 
perforin is nearly undetectable. The signal reappeared after 4 h without monensin and further 
increased further over time. Although, it did not reach the levels detected in untreated or DMSO-
treated cells. Additionally, as control the amount of granzyme B was detected using the monoclonal 
antibody Gb11. The treatment is not affecting the level of intracellular granzyme B in the NK cells 
(Fig. 4.23 B). Monensin-induced reduction of perforin was also verified via flow cytometry using the 
antibody 'G9. In treated NK cells perforin was reduced by 69 % compared to control treated NK cells, 
whereas the amount of CD107a remained unaffected (Fig. 4.23 C). Interestingly, the different donors 
already showed large variation in their baseline expression of perforin and CD107a, but the trend was 
the same nevertheless. 
 
 
Fig. 4.23: Monensin leads to depletion of mature perforin in NK cells. (A) NK cells were treated for 1 h with different 
monensin concentrations or the solvent control EtOH. Subsequently, cell lysates probed for perforin (PF344) and actin as a 
loading control. (one representative example; n=3) (B) Pre-treated NK cells were washed and incubated for 24 h without 
the monensin present. Samples were taken every 4 h and analyzed for perforin and actin expression as in (A). (one 
representative experiment; n=3) (C) Intracellular staining for perforin (clone: 'G9; left) and CD107a (clone: H4A3, right) 
after treatment. Histograms of one representative experiment are shown (solid grey - isotype control of monensin-treated 
cells; specific staining of EtOH- (black line) and monensin-treated (red-line) NK cells). Right panels show the 
quantification of three different donors. 
 
For functional assays NK cells were pre-treated for 1 h with 8.6 µM monensin. Since the observed 
effect was reversible, the compound was present during the assays. Next the ability of pre-treated NK 
cells to form conjugates with K562 target cells was examined. The treatment slightly reduced 
conjugate formation compared solvent-treated cells (Fig. 4.24 A). On NK cells incubated with 
monensin, the surface expression of CD107a is slightly increased after 2 h co-incubation with the 
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targets. This was expected since monensin is widely used in degranulation assays to prevent the fast re-
internalization and degradation of CD107a (Fig. 4.24 B). The titration of monensin in the 
cytotoxicity assay showed a dose-dependent reduction in lysis resembling the reduction of perforin 
seen in Fig. 4.24 A. The lowest concentration did not affect the lysis, whereas higher concentrations 
of 8.6 µM and 10.8 µM potently reduced the lysis to a similar extent (Fig. 4.24 C). Surprisingly, the 
half-life of conjugates formed by monensin-treated compared to EtOH-treated NK cells was not 
altered. Although the determined half-lives differed between individual donors the stability of the 
conjugates of monensin-treated NK cells was always comparable to control conditions (Fig. 4.24 D). 
Thus, although treatment with monensin prevents target cell death the detachment of NK cells from 
the target cells is unchanged. 
 
 
 
  
 
Fig. 4.24: Monensin-treatment of NK cells 
reduces the cytolysis of K562 target cells, but 
does not affect the stability of NK:K562-
conjugates. If not indicated otherwise, NK 
cells were pre-treated for 1 h with 8 
monensin or the solvent control EtOH and 
the inhibitor present during the assays. As 
targets K562 cells were used. (A) Conjugate 
formation assay. (n=3). (B) CD107a (H4A3) 
surface expression after 4 h coincubation with 
K562 cells. (E:T=1:2; n=3) (C) Standard 4 h 
51chromium release assay.   (E:T=1:4; n=2)   
(D)   Conjugate   decay   assay. 
The decay curve of one representative example and the summary of 4 different donors are shown. (ns = not significant) (A-
C) Values are shown as mean ± SD. 
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5. Discussion 
5.1 Tools to investigate the detachment process 
The understanding of NK cell mediated cytotoxicity and the requirement of the formation of the NK 
cell synapses are a main focus in NK cell research. The increasing understanding of its regulation and 
especially the deregulation in disease leads to new approaches in therapy. The steps of the synapse 
formation up to the release of lytic granules and the induction of apoptosis in target cells are fairly 
well, although not fully deciphered. Since it was found that NK cells can kill not only one target, but 
in some cases consecutively up to 16 (Bhat&Watzl, 2007; Choi&Mitchison, 2013; Vanherberghen et 
al., 2013), the question what leads to subsequent breakage of the synapse and the detachment from the 
target cell becomes more intriguing.  
Here, we used a flow cytometry-based approach originally described in 2009 to determine factors 
influencing the detachment (Culley et al., 2009). The determined half-life for conjugates formed 
between human IL-2 activated NK cells and the target cell line K562 was about 47 min. It is 
important to take into consideration that this is an artificial in vitro system and therefore the half-life 
in vivo might be different. The duration of NK:target cell-contacts described in the literature is quite 
diverse most probably depending on multiple factors such as pre-activation of the NK cells, the type of 
effector or target cell or the assay system as such (Chauveau et al., 2010; Choi&Mitchison; 
Vanherberghen et al., 2013). Additionally, we observed differences in the half-lives between individual 
donors. This is in line with data from other groups, that also observed differences even between NK 
cells of single donors (Vanherberghen et al., 2013).  
Minor changes in the assay set up as varying E:T ratios or pre-coincubation times have only slight 
influences on the determined half-life. This indicates that the half-life determined in the assay is 
consistent and changes most probably dependent only on cell-intrinsic factors. 
Enabling conjugates to form normally and subsequently interfere with the detachment in our system 
e.g. by using inhibitors allows identification of factors that might be important for sustained 
conjugation or detachment. Once an important component is identified, more specific and more 
physiological approaches can be applied. Therefore, the established system provides a fast and 
comparably easy technique to determine events or molecules involved in the detachment process. 
Furthermore, to visualize the detachment process of NK cells from target cells we established an assay 
based on life cell imaging and a flow chamber system. The low magnification did not allow definition 
of mature synapses, therefore we refrained from classifying the observed contacts as conjugates. 
Interestingly, the trend for the half-life of the NK:target cell contacts was similar compared to the 
results of flow cytometry-based assay. Varying the assay conditions of the microscopy-based assay, e.g. 
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application of inhibitors to the medium flow or changing target cell densities will allow gaining further 
information about the NK cell detachment.  
 
5.2 Presence of a new susceptible target causes detachment 
Serial killing increases the efficiency of NK cell cytotoxicity. Some NK cells are able to consecutively 
kill multiple times (Ullberg&Jondal, 1981; Bhat&Watzl, 2007; Tomescu et al., 2009; 
Choi&Mitchison, 2013; Lopez et al., 2013; Vanherberghen et al., 2013). Interestingly, Choi and 
Mitchison showed that the availability of a new target in close proximity induces detachment from a 
previous target. Moreover, it increases the speed of the killing events, a phenomenon they described as 
“kinetic priming” (Choi&Mitchison, 2013). In line with these observations, we found that addition of 
an exceeding amount of targets to pre-formed conjugates accelerated the NK cell detachment from the 
initial targets. This indicates that engagement of a new susceptible target induces processes leading to 
detachment. This could possibly include redistribution of adhesion molecules, activating receptors and 
the according signaling molecules. In contrast, fixed target cells did not decrease the conjugate half-
life. This indicates, that only susceptible targets affect the NK cell detachment. It is known, that NK 
cells can interact with susceptible and unsusceptible targets at the same time (Eriksson et al., 1999). 
The spatial separation of activating and inhibitory signaling events is important to protect harmless 
bystander cells. Consequently, even though the remaining contact to a previous target keeps the NK 
cell in an activated status, the activating signaling that is locally induced by the new target still might 
have to overcome inhibition. This additional activating signaling at different location in the cell might 
induce mechanisms causing detachment. On the other side, bystander cells inducing local inhibitory 
signaling, e.g. by MHC class I molecule expression might not induce the detachment. Interestingly, in 
the study of Choi and Mitchison, the NK cells remained attached over long periods if no new target 
was in proximity, even after induction of apoptosis in the target cell. The remaining question is how 
much and for how long an apoptotic cell could provide activating stimuli. 
 
5.3 Surface phenotype of detached NK cells 
Cell-cell interactions influence the phenotype and induce gene-expression and many other functions.  
Ligation-induced up- or down-modulations of surface receptors have been described as mechanism for 
the regulation of NK cell function. Therefore, we investigated surface pattern changes of human NK 
cells induced by contact to HeLa cells. Some of the tested receptors were not regulated. For CD56 no 
ligand was found yet. The lack of a ligand could explain, why the expression of the receptor does not 
require regulation. Similarly, changes in the expression of LFA-1 were not expected. Although it is 
triggered by ICAMs during cell-cell interaction, ligation-induced modulation of its surface level was 
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not described so far. Its function is rather regulated via clustering and conformational changes. 
Although ligands for DNAM-1 and NKp44 are expressed on HeLa cells (El-Sherbiny et al., 2007; 
Jarahian et al. 2011; Baychelier et al., 2013), the surface expression of these receptors was not altered 
after detachment. This indicates, that the receptors are either not modulated or the down-regulation 
takes longer than the observation time of the assay. Alternatively, the expression of the ligands could 
be too low to induce effective changes in the receptor surface exposure. In contrast, levels of other 
receptors were either increased or decreased. In consistence with the literature, we found reduced 
expression of 2B4 and NKG2D after target cell contact (Sandusky et al., 2006; Roda-
Navarro&Reyburn, 2009). The HeLa cells used here were transfected with CD48, the ligand for 2B4 
and expression of stress-induced NKG2D-ligands on HeLa cells was described before (El Sherbiny et 
al., 2007). The reduction of surface levels of these receptors therefore most probably was due to ligand 
interaction. A similar trend was observed for NKp46, although it was not significant. That indicated 
that the same mechanism might also be true for this receptor. The hypothesis is supported by data that 
show binding of NKp46 to HeLa cells (El Sherbiny et al., 2007). The reduction in the surface levels of 
these receptors could also be due to exchange of membrane parts and the associated receptors with the 
target cell along the synapse. This process was suggested to be involved in the regulation of NK cell 
activity (Roda-Navarro et al., 2006; Jarahian et al., 2011; Baychelier et al., 2013). In contrast to 
reduced expression, some of the analyzed receptors showed increased surface levels on late-detaching 
NK cells. This was expected for CD69 and CD107a. CD69 was described as an early activation 
marker for lymphocytes, which is rapidly upregulated on the surface after activation. Similarly, 
increased CD107a expression as marker for degranulation indicates that the NK:target cell-contacts 
were functional leading to NK cell activation. Surprisingly, a similar trend of increased expression 
levels on late detaching NK cells was also seen for NKp30 and NKG2A. B7-H6 as ligand for NKp30 
was found on HeLa cells (Zhang et al., 2012; Fiegler et al., 2013). Up-regulation of surface expression 
in this short time frame seems rather unlikely. A plausible cause for this observation could be due to an 
enrichment of certain subpopulations with increased expression of these receptors during the assay. 
This is particularly interesting for NKG2A, since this observation is in accordance with the “rheostat 
model” for NK cell education. It describes a possible mechanism, why NK cells that lack inhibitory 
receptors for self-MHC I become hyporesponsive instead of hyperresponsive. In other words, NK 
cells with a high expression of inhibitory receptors and thereby increased sensitivity to inhibition 
display a strong responsiveness to activating signals (Brodin et al., 2009; Joncker et al., 2009). 
Recently, a study showed that licensed NK cells form more stable conjugates than unlicensed NK cells 
(Thomas et al., 2013). Therefore, the high NKG2A expression on the detaching NK cells could mark 
a strong effector phenotype that shows increased ability to remain attached to the targets. Taken 
together these data indicate that licensing not only increases the initial adhesion, but also the ability to 
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maintain the conjugates. In this context it is important to note, that the receptor would not be 
triggered in this specific case, since there is no ligand expressed on HeLa cells (Palmisano et al., 2005). 
It would be interesting to also compare other inhibitory NK cell receptors, e.g. KIRs, for their 
expression after target cell contact. Unfortunately, the NK cells here expressed the KIRs analyzed only 
very little or not at all. In general, we conclude that the interaction of NK cells with target cells leads 
to alterations in the surface expression pattern of several receptors, possibly regulating their activity. 
But further studies are required to uncover the correlation between certain phenotypes and the ability 
to remain in conjugates. Additionally, considering the hypothesis that receptor down-modulation is a 
mechanism for reduction of activating signaling it would be interesting to prevent of internalization, 
e.g. by inhibition of endocytosis. 
 
Surface levels of activating receptors are not only modulated by internalization. Cleavage of CD16 
after activation by various cell surface metalloproteinases has been described recently (Peruzzi et al., 
2013; Romee et al., 2013; Zhou et al., 2013; Parsons et al., 2014). Other surface receptors are possibly 
regulated in a similar way. Thus, we inhibited MMPs (matrix metalloproteinases) and ADAMs (a 
disintegrin and metalloproteinase) with broad-spectrum inhibitors. But the treatment neither affected 
the NK cell-mediated cytotoxicity nor the stability of NK:target cell conjugates. Thus, either the 
treatment was not efficient enough to inhibit all metalloproteinases at the cell surface, or they have no 
impact on the surface receptors and thereby on the strength of cell-cell interaction. 
 
5.4 Signaling and detachment 
NK cell activity is strictly regulated by integration of activating and inhibitory signaling. Triggering of 
integrins or activating receptors induces synergistic and redundant signaling pathways, which can be 
interrupted at early steps by ligation of inhibitory receptors (Long et al., 2013). Conjugate formation 
and induction of effector functions depend on certain key factors, e.g. Src- and Syk-family kinases, 
PI3K or PLC" (Brumbaugh et al., 1997; Jiang et al., 2000; Watzl&Long, 2010). In accordance with 
the literature, we found that inhibition of these molecules, except for PI3K, reduced the cytotoxicity of 
the NK cells. Hence, we analyzed the influence of these signaling molecules on the stability of 
NK:target cell conjugates by applying the specific inhibitors in the decay assay.  
To analyze their impact on the conjugate stability and detachment without disturbing initial steps of 
the synapse formation, the inhibitors were added after the conjugates were formed. All inhibitors 
tested reduced the half-life of the formed conjugates. The deceleration of the detachment was stronger 
when Src kinases, PI3K or PLC" were targeted compared to the impact of Syk kinase inhibition. Src 
kinases or PLC" inhibition had a very strong effect, leading to almost immediate collapse of most of 
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the conjugates. Considering the importance for Src family kinase-mediated phosphorylation in the 
signaling pathways of all activating receptors, this was not surprising (Watzl&Long, 2010; James et 
al., 2013). Similarly, PLC" activity was described to be crucial for NK cell function (Regunathan et al., 
2005; Tassi et al., 2005; Caraux et al., 2006). Inhibition of PI3K required for generation of PIP3 
surprisingly only slightly affected the cytotoxicity, which is in contrast to literature (Eissmann&Watzl, 
2006; James et al., 2013). A plausible cause could be the pre-activation of the NK cells by IL-2 that 
might render them less susceptible to PI3K inhibition. Nevertheless, interfering with PI3K activity 
affected the stability of conjugates, although less effective than Src kinase or PLC" inhibition. The 
least effect on the conjugate half-life was induced by Syk kinase family inhibition. Specifically 
targeting Syk had the same effect as using an inhibitor with a broader spectrum also targeting other 
Syk family kinases. This shows, that inhibition of Syk is not compensated by other Syk family kinases 
and that it has less impact on conjugate stability. Thus, these data indicate that besides the initial 
activating trigger required for induction of synapse formation, the continuance of early signaling is 
mandatory to maintain contacts. The aNKIS is a dynamic structure. For instance receptor-ligand 
interactions are constantly broken and regenerated leading to new signals. Phosphorylation and 
dephosphorylation events as basis for regulation of signaling molecules are subject to a constant turn 
over. Consequently, to facilitate the NK cell to perform its task, constant reactivation of the signaling 
molecules is mandatory. A main process induced by these early signaling events is the formation of F-
actin facilitating actin cytoskeleton rearrangements. Recruitment and clustering of receptors are 
dependent on F-actin. Hence, loss of the anchor provided by the actin cytoskeleton would induce the 
redistribution of receptors and integrins and thereby weaken the contact between NK and target cell.  
 
Besides these early events, we were interested in the importance of events further down stream. The 
MAP kinase pathway induced by PI3K activation was described to be required for granule polarization 
and exocytosis (Vyas et al., 2002). We targeted MEK1/2 and p38 with chemical inhibitors. It was 
shown before, that MEK inhibition only partially influences NK cell-mediated cytotoxicity 
(Abraha&Whalen, 2009). In consistence with these data, interfering with MEK1/2 activity induced a 
moderate reduction of target cell lysis. Interestingly, MEK signaling was not required for conjugate 
stability. p38 was described to be activated by CD16 ligation or target cell contact (Chini et al., 2000; 
Trotta et al., 2000), although its inhibition was only partially reducing the lysis. In our experiments we 
did not observe an effect induced by p38 inhibition neither on cytotoxicity nor on the conjugate 
stability. Therefore, we concluded that later events such as MAP kinase signaling were required for 
full cytotoxicity, but not for the stability of conjugates.  
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Another signaling molecule described to be important for NK and T cell function is PKC!. The 
serine-threonine kinase of the novel, Ca2+-independent PKC subfamily, was described to have an 
essential role in the breakage of synapses of CD4+ T cells in mice and humans (Sims et al., 2007; Beal 
et al., 2008). However, this is discussed controversially since PKC! also was found to be required for 
IS stability by increasing LFA-1 avidity (Letschka et al., 2008; Kong&Altman, 2013). In the human 
NK cell line YTS PKC! was shown to phosphorylate WASp-interacting protein (WIP). WIP 
phosphorylation is not required for its interaction with WASp, but was proposed to be required for 
the recruitment of actin and myosin IIA to the WIP-WASp-complex (Krzewski et al., 2006) and 
thereby may have a role in regulating actin cytoskeleton rearrangements. Inhibition of PKC! reduced 
the NK cell-mediated cytotoxicity, but did not affect the detachment from target cells. To verify the 
results, we tested the !-specific pseudosubstrate inhibitor or knocked down the PKC! protein. 
Surprisingly, these treatments did not confirm the results induced by the broad-spectrum inhibitor. 
This indicates, that other PKC isoforms are required for NK cell cytotoxicity and that in contrast to 
the observation in T cells PKC! does not affect the stability of the IS formed by NK cells. 
 
Regulation of NK cell activity by inhibitory signaling is dependent on various phosphatases as e.g. 
SHP-1 or -2. The dephosphorylation of early signaling molecules such as Vav1 or the phosphorylation 
of Crk led to interruption of activating signaling pathways (Stebbins et al., 2003; Peterson&Long, 
2008; Abeyweera et al., 2011). We hypothesized that activity of phosphatases at advanced stages of 
cytolytic interaction might be a regulatory mechanism. Pervanadate is a common inhibitor of protein-
tyrosine phosphatases. It irreversibly oxidizes their catalytic cysteine (Huyer et al., 1997). Treatment of 
NK cells with pervanadate led to a reduction of their ability to form conjugates and consequently to a 
reduction of target cell lysis. Since already conjugate formation was impaired we were not able to 
analyze its effects on the detachment. Another family of phosphatases is serine-threonine (S/T) 
phosphatases. Several signaling molecules e.g. Akt and Erk are activated by phosphorylation of serine 
or threonine residues. Thus, we chemically inhibited the phosphatases PP1, PP2A and PP3A. 
Treatment with okadaic acid did not affect NK cell-mediated cytotoxicity or the detachment process. 
In contrast inhibition by calyculin A strongly decreases target cell lysis and interfered with conjugate 
stability. Bajpai and Brahmi found a similar effect of okadaic acid and calyculin A in the NK cell line 
YT-Indy and described two proteins that showed increased kinase activity in calyculin A-treated cells, 
but these proteins have not been identified yet (Bajpai&Brahmi, 1994; 1996). PP3A is only inhibited 
by okadaic acid. The specificity of both inhibitors for PP2A is comparable, whereas calyculin A has a 
higher inhibitory effect on PP1. Thus, since only calyculin A showed effects on the NK cell-function 
these effects are most likely due to inhibition of PP1. This finding reveals a possible role for this 
phosphatase for NK cell mediated cytotoxicity and for maintenance of NK:target cell contacts. In T 
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cells PP1 was described to dephosphorylate and thereby activate cofilin (Samstag, 2003). It is required 
in T cell migration and activation by depolymerizing and/or severing actin filaments (Samstag et al., 
2013). So far, the role of cofilin in NK cells has not been studied. Therefore, the here observed effect 
could be due to a yet unknown role of cofilin A in NK cells or the activity of two yet unknown kinases. 
 
5.5 Energy and detachment 
Berke and Gabison stated already in 1975 that formation, but not maintenance of T:target cell 
conjugates is energy-dependent (Berke&Gabison, 1975). In 1999, Davis and colleagues found that 
formation of inhibitory synapses is not affected by depletion of ATP (Davis et al., 1999). The 
importance of ATP levels in NK cells for their function has not been evaluated yet. Reduction of 
intracellular ATP-levels by sodium azide treatment affected the ability of NK cells to form conjugates 
and moderately decreased their cytotoxic function. Additionally, depleting ATP led to a rapid loss of 
conjugate stability. For synapses between NK cell and macrophages it was described, that treatment 
with azide led to a reduction of formed conjugates. This and the data generated here indicate that NK 
cell functions are at least partly dependent on ATP. This is in line with observations made by Abarca-
Rojano and colleagues (Abarca-Rojano et al., 2009). They found that NK cells upon target cell contact 
rapidly consume their metabolic energy and that mitochondria reorganize towards the synapse, 
possibly to compensate the local loss of energy. ATP is required as substrate for kinases 
(Hubbard&Till, 2000) as well as by ATPases as the vacuolar H+-ATPase or myosin IIA (Sanborn et 
al., 2009; Stewart et al., 2013). Thus, ATP is a requirement for full NK cell function. We inhibited 
vacuolar H+-ATPases and the ATPase myosin IIA. Neither of the molecules was influencing the 
intracellular ATP-level in NK cells that were not challenged with target cells. This might be different 
during NK:target cell interaction. Additionally, inhibiting a single molecule class might not strongly 
impact the ATP consumption, since many different steps require energy. Furthermore, the importance 
of ATP for conjugate stability is in line with the observations for the significance of early signaling 
events. The kinases recruited by activating receptors require ATP as substrate. Therefore, reduction of 
the substrate would decrease the activating signaling and thereby destabilize the NK:target cell 
conjugates. 
 
5.6 The cytoskeleton and detachment 
The dynamics of the cytoskeleton are indispensible for NK cell effector functions (Brown et al., 2011; 
Rak et al., 2011; Brown et al., 2012; Mace et al., 2014). Already very early steps in synapse formation, 
such as receptor clustering and polarization of the cell are dependent on a flexible actin cytoskeleton. It 
was shown, that either stabilizing or destabilizing the F-actin affects conjugate formation and cytolytic 
.5+)1++5'*!
 
 72 
activity (Orange et al., 2002; Wulfing et al., 2003; Rak et al., 2011). According to this finding, 
interfering with actin rearrangements abolished NK cell-mediated lysis of the target cell. When 
interfering with the actin dynamics in already formed conjugates, we saw a rapid detachment as early 
as 10 min after treatment in either condition. Therefore, we conclude that even in formed lytic 
synapses the actin cytoskeleton needs to reorganize in order to maintain the conjugates. Additionally, 
Gross and colleagues found, that also reorganization of the target cell cytoskeleton is required for 
conjugate formation (Gross et al., 2010). Since in our system NK as well as target cells are affected by 
the treatment, integrity of the target cell cytoskeleton might also be important to stabilize conjugates.  
 
On the contrary, in our system microtubule dynamics were less important for these functions. When 
we either stabilized or destabilized microtubules the cytotoxicity of the NK cells was almost not 
affected. This was surprising since convergence of lytic granules to the MTOC, although it is 
independent of microtubule rearrangements, requires intact microtubules (Mentlik et al., 2010). 
However, polarization of the complex of MTOC and lytic granules to the contact site was described 
to be dependent on microtubule and actin reorganization (Mentlik et al., 2010; Lagrue et al., 2013). 
Katz and colleagues found, that conjugate formation is not affected by microtubule inhibition, whereas 
lysis was suppressed (Katz et al., 1982). In our approach to study detachment we only saw effects if 
microtubules were destabilized and these were minor compared to the effects seen by interference with 
the actin cytoskeleton. Therefore, the presence of microtubules but not their dynamics seems to be 
required for conjugate stability. 
 
5.7 Target cell survival and detachment 
Our data revealed a possible correlation between target cell death and NK cell detachment. Prevention 
of target cell death by inhibiting caspase-cascades induced by granzyme B failed. This could be 
partially explained by the observation that granzyme B also induces caspase-independent apoptosis 
mechanisms (Trapani et al., 1998; Beresford et al., 1999; Lieberman, 2003). Additionally, the impact 
on the target cell by NK cell effector functions could be too robust to be easily interfered with. Other 
cytotoxic molecules released besides granzymes during degranulation, e.g. perforin or granulysin are 
also affecting the survival of the target cell. Similarly, attempts to increase the susceptibility to lysis by 
inhibiting the target cell proteasome were not successful. 
Consequently, we interfered with the effector mechanisms of the NK cells aiming to prevent target 
cell death. Targeting myosin IIA that is required for lytic granule exocytosis in NK cells (Kovacs et al.; 
Andzelm et al., 2007; Sanborn et al., 2009; Sanborn et al., 2011) only slightly reduced granule 
exocytosis and also affected the target cell lysis only partially. Myosin IIA-inhibited NK cells showed 
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normal conjugate formation, but interestingly the decay of their conjugates was decelerated. The 
observed effect was mild but consistent for all donors tested. On that account, either the degranulation 
as such or the reduced target cell death might have influence on the stability of conjugates. 
Because we could not fully prevent degranulation and release of cytotoxic effector molecules, we 
depleted mature perforin in NK cells. By targeting the V-H+-ATPase in the membrane of lytic 
granules we induced an increase in the pH of lytic granules. This led to inhibition of cathepsin L that 
cleaves immature perforin and thereby generates its active form. Additionally, the increased pH is 
assumed to induce degradation of mature perforin probably as mechanism to protect the NK cell 
(Kataoka, 1994; Kataoka et al., 1996). We used two different inhibitors of the V-H+-ATPase. In both 
cases, NK cells were still able to normally form conjugates, but their cytotoxicity was abrogated or at 
least strongly decreased. And interestingly, in both cases the detachment of NK cells from target cells 
was dramatically decelerated. The arising question remains, if this is due to prevented target cell death 
or if this effect is caused by inhibition of the V-H+-ATPase as such. Additionally, there could be 
unknown side effects of the compounds. 
To interfere with perforin levels in a similar way, but without targeting the V-H+-ATPase, we used 
monensin. The H+-ionophore reversibly increases the pH in lytic granules and thereby induces 
depletion of mature perforin. As seen for V-ATPase inhibition this led to almost full reduction of NK 
cell-mediated cytotoxicity. But surprisingly monensin-treatment had no influence on the stability of 
the conjugates. The ionophor induces a broad spectrum of unspecific effects e.g. vacuolarization 
(Pedersen et al., 1982; Pohlmann et al., 1984). Thereby a prolonging effect on the half-life by perforin 
depletion could be masked by other changes in the cell induced by the treatment. Alternatively, the 
observation indicates that the effect seen by V-H+-ATPase inhibition is not due to prevented target 
cell death, but reveals a new role of the ATPase. 
The vacuolar H+-ATPase has been reported to be involved in receptor-mediated endocytosis, 
intracellular membrane trafficking or also release of neurotransmitters. Additionally it was shown to be 
involved in virus-uptake e.g. via CD4 during HIV infections (Geyer et al., 2002; Jefferies et al., 2008). 
In osteoclasts the V-ATPase is required for acidification and interestingly was found to have an actin-
binding site.  Recently El Far and Seagar suggested a role of the V-ATPase in neurotransmitter 
release by interacting with SNARE proteins (El Far&Seagar, 2011). So far V-ATPases have not been 
specifically studied in NK cells. Therefore, no other function except for acidification in lytic granules 
was investigated yet. Our results indicate that there might be an additional functional role of V-
ATPases in NK cells that has not been investigated yet. 
 
In this study, we used three assay systems that characterize of the detachment process of NK cells from 
target cells. Using flow cytometry-based assays we show that recently detached NK cells display 
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changes in their surface expression pattern. This could be caused by regulatory mechanisms, which are 
important for controlling NK cell cytotoxicity. In line with this, we found that the stability of 
NK:target cell conjugates requires ongoing early activating signaling and a dynamic cytoskeleton. 
Supporting these findings, we observed that also ATP, e.g. as substrate for kinases or ATPases, must 
be available. In contrast signaling molecules further down-stream, or cell surface-located 
metalloproteinases are dispensable for the maintenance of conjugates. Inhibiting the vacuolar H+-
ATPase and thereby depleting mature perforin in the NK cells almost completely blocked the 
detachment of NK cells from target cells. The question remains if this is due to the prevention of the 
target cell death or induced by the interference with the V-ATPase function. The latter hypothesis 
would be supported by the observation that depletion of mature perforin by monensin did not affect 
the stability of NK:target cell conjugates. Further studies in this system and in addition, the 
visualization of the detachment process via life-cell imaging will increase the understanding of the 
events leading to detachment and resolving the sequence of this process. This might provide insights 
in NK cell function, which are important for augmentation of NK cell-mediated cytotoxicity by 
possibly increasing their ability for serial killing. 
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7. Abbreviations 
 
# Alpha 
ADCC Antibody-dependent cellular cytotoxicity 
AICL Activation-induced C-type lectin 
aNKIS Activating NK cell immunological synapse 
APC Antigen presenting cell 
ATP Adenosine triphosphate 
BID BH3-interactin domain death agonist 
BSA Bovine serum albumin 
CD Cluster of differentiation 
CMA Concanamycin A 
CMV Cytomegalovirus 
CTL Cytotoxic T lymphocytes 
DAPI 4',6-Diamidino-2-phenylindole-dihydrochloride 
DC Dendritic cell 
DMEM Dulbecco's Modified Eagle Medium 
DMSO Dimethyl sulfoxide 
DNAM-1 DNAX accessory molecule-1 
DOCK8 Dedicator of cytokinesis 8 
EAT-2 Ewing’s sarcoma-associated transcript-2 
EBV Eppstein-Barr virus 
EDTA Ethylenediaminetetraacetic acid 
E:T ratio Effector to target cell ratio 
FACS Fluorescence-activated cell sorting 
Fc Fragment crystallizable 
FCS Fetal calf serum 
Fig. Figure 
FITC Fluorescin isothiocyanate 
" Gamma 
GEF Guanine nucleotide exchange factors 
GMCSF Granulocyte-macrophage colony stimulating factor 
h Hour 
HLA Human lymphocyte antigen 
ICAM Intercellular adhesion molecule 
ID Inner diameter 
IFN Interferon 
"##2%7"!5'*+!
 
 96 
Ig Immunoglobulin 
IgG Immunoglobulin G 
IL Interleukin 
ILT Immunoglobulin -like transcript 
IMDM Iscove's Modified Dulbecco's Medium 
iNKIS Inhibitory NK cell immunological synapse 
IS Immunological synapse 
ITAM Immunoreceptor tyrosine-based activation motif 
ITIM Immunoreceptor tyrosine-based inhibition motif 
ITSM Immunoreceptor tyrosine-based switch motif 
IU International units 
kDa Kilo Dalton 
KIR Killer cell immunoglobuline-like receptor 
LAT Linker for the activation of T cells 
LFA Lymphocyte function-associated antigen 
LSM Lymphocyte separation medium 
mAb Monoclonal antibody 
MAPK Mitogen activated protein kinase 
MCMV Murine cytomeglovirus 
MEK Mitogen-activated protein kinase kinase 
MFI Mean fluorescence intensity 
MHC Major histocompatibility complex 
min Minutes 
MMPs Matrix metalloproteinases 
MTOC Microtubule organizing center 
NCR Natural cytotoxicity receptor 
NEAA Non-essential amino acids 
NKC Natural Killer gene complex 
NK cell Natural Killer cell 
NKIS NK cell immunological synapse 
NRSB Non-reducing sample buffer 
NTAL Non-T cell activation linker 
PBL Peripheral blood lymphocytes 
PBMC Peripheral blood mononuclear cells 
PBS Phosphate buffered saline 
PCNA Proliferating cell nuclear antigen 
PE Phycoerythrin 
PFA Paraformaldehyde 
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PI3K Phosphatidyl-inositol-3-kinase 
PIP2 Phosphatidylinositol (4,5)-bisphosphate 
PIP3 Phosphatidylinositol 3,4,5-trisphosphate 
PKC Proteinkinase C 
PLC Phospholipase C 
PLL Poly-L-lysin 
PMA Phorbol 12-myristate 13-acetate 
PMSF Phenylmethysulfonyl fluoride 
PVDF Polyvinylidene fluoride 
RNA Ribonucleic acid 
RNAi RNA interference 
RPMI Roswell Park Memorial Institute 
RSB Reducing sample buffer 
SAP SLAM-associated protein 
SDS Sodium dodecyl sulfate 
SDS-PAGE SDS polyacrylamide gel electrophoresis 
SHP SH2 containing protein tyrosine phosphatases 
siRNA Small interfering RNA 
SNARE Soluble-N- ethylmaleimide-sensitive-factor accessory-protein receptor 
SOCE Store-operated Ca2+ entry 
Syk Spleen tyrosine kinase 
! Theta 
TCR T cell receptor 
TNF Tumor necrosis factor 
TRAIL TNF-related apoptosis inducing ligand 
Tyr Tyrosine 
WASp Wiskott Aldrich-syndrome protein 
WIP WASp-interacting protein 
WB Western Blot 
( Zeta 
ZAP70 Zeta chain-associated protein kinase 70 
 
 
 
 
 
 
